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ABSTRACT 
 
 
  
ABSTRACT 
Type 2 diabetes (T2D) is a multifactorial disease and genetics play a crucial role in its 
pathogenesis. The current research was aimed to report the economic burden, risk factors and 
susceptible genes of T2D in Pakistani population. A total of 591 subjects were included in 
epidemiology study and 458 were further evaluated for genetic analysis.The selection of 
candidate genes was based previous studies and their role in glucose homeostasis and 
complications of diabetes. The selected genes with single nucleotide polymorphisms (SNPs) 
were CDKL1 (rs7756992 A>G), NPPA (rs5064 G>A), GNB3 (rs5443 C>T), PPARG (rs1801282 
G>C), IL6 (rs1800796 C>G), IDE (rs6583813 C>T, rs7910977 C>T), POU2F1 (rs3767434 
A>T, rs10918682 A>T, rs2146727 A>G), WFS1 (rs734312 A>G), PON1 (rs854560 T>A), IL1α 
(rs1800587 C>T) and IL1β (rs1143634 C>T). Genotyping was performed by Nested PCR (DNA 
amplification) and direct sequencing. Incidences of diabetes were highest in age group of 41-60 
years with 61.42% of total diabetes cases. Urban Men (10.69%) and women (21.14%) were 
diagnosis at early age ≤ 35yearsas compare to rural men (2.94%) and women (4.11%) 
respectively. Overweight (Body Mass Index > 25) and positive family history of diabetes were 
strong predictors of disease onset at early age with P = 0.01 and P = 0.003 respectively. 
Retinopathy and nephropathy were three times higher in rural population than urban residents. 
Average annual cost per patient was 210.92US$ (19,157 PKRs) and insulin treatment was of 
higher cost (P < 0.001) in comparison to oral medication. Families were spending 12-20% of 
their income to manage the disease. Genetic results indicated that rs7910977 in IDE showed 
significant association with the development of T2D [P = 0.012, OR = 1.677 (95% CI = 1.112-
2.438)].Thers10918682 in POU2F1 was associated with T2D [P< 0.001, OR = 3.606 (95% CI= 
2.165- 6.005)] in Pakistani population. The rs854560 in PON1was associated with incidences of 
T2D and increased the risk of cardiovascular complications [P = 0.031, OR= 0.663 (95% CI = 
0.455-0.965)] in diabetics. The rs1801282 in PPARG and rs1800796 from IL6 were significantly 
associated with T2D [P = 0.004, OR = 2.188 (1.254, 3.815); P = 0.0001, OR = 0.394 (0.265, 
0.584)].Genotype analysis showed the association of rs5443, rs1801282 and rs1800796 with the 
onset of T2D (P< 0.05) where the risk genotypes were TT, CG and GG respectively. Haplotype 
analysis of rs1800587-rs1143634 depicted C-C haplotype increased the susceptibility to diabetes 
(P< 0.05). Haplotype G-A-A from rs2146727-10918682-rs3767434 was protective against 
diabetes (P< 0.01) and G-G-A exhibited the association with T2D (P< 0.01). HaplotypeC-T from 
rs6583813-rs7910977 was protective against diabetes (P = 0.02). Linear regression analysis 
between demographic characteristics and genotypes showed a positive association of CC from 
rs1800796 with family history of diabetes (P< 0.05). The CT genotype from rs7756992 was 
associated to complications of T2D (P< 0.05).  
Conclusion:SNPs in KCNQ1, GNB3, PPARG, IL6,CDKLI, IDE, PON1, WFS1, POU2F1, 
ITGA2, IL1α and IL1β associated with T2D in Pakistanis. Diabetes is the one of major health 
issue in Pakistan making the socioeconomic and health problems for the nation. Further studies 
are needed to develop a comprehensive program for targeting susceptible communities and 
prevention of diabetes. 
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CHAPTER 1 
INTRODUCTION 
1.1 Background  
Ancient Egyptian physician Hesy-Ra first described diabetes in 1552 Before 
Christian Era (BCE) as “passing of too much urine” (Nunn, 2002). In 250 BCE, 
Arateus gave the description of diabetes as “the melting down of flesh and limbs into 
urine” as well as also described the destructive nature of this disease by coining the 
term "diabetes" from the Greek word for "siphon" (Medvei, 1993; Sattley, 1996; 
Ahmed, 2002). 
There are three types of diabetes such as Type 1 diabetes, caused by the 
immune destruction of islets insulin-secreting beta cells. Gestational diabetes is found 
in pregnant women in whom glucose intolerance occurs that increases the chances of 
onset of other types of diabetes.  Type 2 diabetes (T2D) is a multifactorial disease, 
characterized by hyperglycemia, which results from disorder in pancreatic β-cell 
function, dysregulation in insulin action and secretion (Stumvoll et al., 2005; Feig et 
al., 2008). T2D leads to hyperglycemia and when poorly treated, increase urine 
production, compensatory thirst with excessive fluid intake, blurred vision, lethargy 
and changes in energy metabolism. T2D may be provoked by pregnancy, medications 
and organic pollutants (Rignell-Hydbom et al., 2009). It is known as most common 
and comprised the 90% to 95% of all diagnosed cases of diabetes. The diagnosed 
patients of T2D have blood glucose level more than 125 mg/dl (before or after 
breakfast) or relative amount of glucose level in blood may ≤ 200 mg/dl by employing 
oral glucose tolerance test (ADA, 2007). The age of diagnosis for the onset of 
diabetes was reported between 20–79 years (Khowaja et al., 2007). Incidences of T2D 
increases with the higher age however, an increasing trend was observed in diabetes 
cases at early ages among Pakistani population as compared to the European countries 
(Samad et al., 2007; Hakeem and Fawwad, 2010).   
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1.2  Diabetes complications  
There is an increase in prevalence of T2D that ultimately increasing the 
number of diabetes-related complications. Such as, diabetes increases the risk of a 
nephropathy, myocardial infarction (increased two times), stroke (increased 2-4 
times), blindness and limb amputation (Rashid et al., 2004; IDF, 2006; CDC, 2007; 
WHO, 2009; AHRQ, 2009). The long duration of diabetes was also reported as a risk 
for the increase in incidences of dyslipidaemia and Coronary Heart Diseases (Naheed 
et al., 2003; Shabbir et al., 2004). Akram et al. (2011), reported the peripheral arterial 
disease (formation of plaque inside the arteries) which is common in people with T2D 
in Pakistan. Recently, it has been reported that diabetic foot ulcers prevail 10.4% 
among diabetic patients especially in males (Basit et al., 2004). Amputation mortality 
due to diabetic foot ulcer is stated as 30% in a year and increases to 50% -70% after 
three-five years respectively (Basit et al., 2006). Pakistan may have over six million 
diabetics and 4% of them have chronic complications associated with T2D (Shera et 
al., 2004; Basit et al., 2006).  A number of different complications were associated 
with the diabetes; increases as the duration of disease increased as the major reported 
complication of diabetes was diabetic nephropathy (Rashid et al., 2004). T2D have a 
number of complications associated with it and it’s very difficult to manage this 
disease because Pakistan is a developing country with insufficient health care budget 
(Basit et al., 2004; Ahmed et al., 2008; Khowaja et al., 2007; Khuwaja et al., 2010). 
1.3 Prevalence 
The prevalence of diabetes was estimated 6.4% in 2010 and mainly was 
affecting 285 millions of adults worldwide. The acceleration graph of diabetes in 
developing and developed countries is estimated 70% and 20%, respectively among 
adults until 2030 (Shaw et al., 2010). According to WHO, one out of twenty deaths 
throughout the world were attributed to diabetes and the Figure is expected to increase 
by two folds in 2030 (WHO, 2010). In USA 7.8% of the population was reported with 
diabetes. Only in a year 1.6 million newly diagnosed cases of diabetes were reported 
(Cowie et al., 2006). Annually greater than 231,000 individual of US and nearly 396 
million of people die worldwide due to diabetes and its complications (IDF, 2009). 
This number was expected to increase by 50 percent in coming decade (WHO, 2009). 
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Prevalence of diabetes was different in both genders in Latin, North Americans, 
Africans, Europeans and East Asians (Tong et al., 2009). 
Asia has passed through economic development, urbanization and transitions 
in values of nutrition (Chan et al., 2009) causing a rapid increase in prevalence of 
diabetes within a short time span (Yang et al., 2010). Asians accounts for nearly 60% 
of diabetic population in the world and in last decade, a rapid increase was seen in 
most of the Asian countries. International Diabetes Federation estimated the 
prevalence of diabetes in 2010, 18.7% in United Arab Emirates, 16.8% in Saudi 
Arabia, 15.4% in Bahrain, 14.6% in Kuwait, 13.4% in Oman and 11.6% in Malaysia 
(IDF, 2010). The endemic condition of diabetes in first five countries are as 50.8 
million in India, 43.2 million in China, 7.1 million in Pakistan, 7.1 million in Japan 
and 7 million in Indonesia (Yang, 2010). 
T2D was identified as a major public health issue in Pakistan (Rees et al., 
2011) and an expected increase in population suffering with T2D from 1995-2025 
was 4.3 million to 14.5 million respectively (King et al., 1998). Pakistan has a 
population of 154 million with 10% of diabetic adults and ranked at 6th number 
according to diabetic population countries (Shera et al., 1995b). In Punjab, Sindh and 
Baluchistan prevalence of diabetes was higher in males in comparison to females 
while in Khyber Pakhtoon Khwaa it was vice versa. The prevalence of T2D was 
reported highest (14%) in Sindh province (Shera et al., 1999; Shera et al., 1999a; 
Shera et al., 2010c). Azad Jammu Kashmir was with 0.95% diabetes prevelence 
where as in Gilgit Baltistan was less than this (Khan and Ahmad, 1994b; Danish et 
al., 2002). The prevalence of T2D has increased among immigrants Pakistanis in 
comparison to the indigenous populations (Barnett et al., 2006). Figure 1.1 showed 
the expected increase in diabetes cases throughout the world from 2000-2030 and 
150% increase was estimated in south Asia (Hossain et al., 2007). 
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Figure 1.1 The prevalence of Diabetes throughout the world and predicting the increase of its epidemics from 2000-2030 (Hossain et al., 2007) 
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1.4 Economic burden of T2D 
Type 2 diabetes is a global public health crisis that threatens the economies of 
all nations, particularly developing countries. Fueled the rapid urbanization, nutrition 
transition and increasing sedentary lifestyles and the epidemic has grown in parallel 
with the worldwide rise in obesity (Hu, 2011). At least 376 billion US Dollar (USD) 
were estimated globally from health care budget to treat and prevent diabetes while 
this number is expected to exceed 490 billion USD in 2030 (IDF, 2010).  
Majority of peoples in South Asia, live on or below the poverty line with a 
lack of healthcare systems, services, absence of national welfare program and health 
insurance. The poor people cannot afford to pay for healthcare services; hence they 
were diagnosed at late stages with diabetes resulting in acute and chronic 
complications (Caro et al., 2002). The T2D prevalence and its complications are 
being increased more rapidly in South Asian population as compare to the other 
regions of the world (Ghaffar et al., 2004).  Mohan et al. (2001), reported that 
diabetes in India was significantly more prevalent in middle class as compare to lower 
class individuals due to intake of nutrient rich diet.  
The annual expenditure for each diabetic person was estimated to be 
approximately 11,580 Pakistani rupees (US$ 197) in Karachi. Medicines accounted 
for the largest share of direct cost (46%), followed by laboratory investigations (32%). 
It was found that increased age, the number of complications and longer duration of 
the disease significantly increase the burden of cost on society (Khowaja et al., 2007). 
Diabetes is going to increase at alarming rate and exerting a huge burden at health as 
well as on economic conditions of the developing countries (Mansoor et al., 2010). 
The cost of care of diabetes is higher and very low budget is allotted to health care, so 
patients can’t afford the cost of care/treatment of diabetes (Khuwaja et al., 2010). 
1.5 Risk factors of diabetes 
T2D was considered as a disease of minor significance throughout the world 
and now taking its place as one of the main threats to human health in the 21st 
century. In last two decades changes in the human environment, behavior and lifestyle 
have resulted in escalating rates of both obesity as well as diabetes (Zimmet et al., 
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2001). The data depicted the metabolic syndrome as more prevalent in men of urban 
population which illustrated the role of diet and lifestyle (Ramírez-Vargas et al., 
2007). Positive family history as well as environmental conditions are risk factors for 
T2D whereas obesity, hypertension, smoking, physical inactivity and highly saturated 
fats in diet considered to be the major risk factors for the development of T2D 
(Dedoussis et al., 2006; Hoek et al., 2008).  
1.5.1  Obesity  
Obesity is known as a major risk factor for the onset of diabetes (Khan and 
Ahmad, 1994a). It causes insulin resistance because various adipose tissues associated 
with enzymes expression involved in the breakdown of lipids, synthesis of 
triglyceride, adipocytokinessynthesis and other functions (Humayun and Shah, 2010). 
Obesity and insulin resistance are the major cause of diabetes. In obesity insulin 
sensitivity decreases and which insulin produced by the β-cells remain insufficient to 
fulfill the body requirement even if they have normal glucose level (Kahn et al., 
2006). Approximately 80% of people with T2D were overweight or obese (Hensrud, 
2001) and obesity identified as a risk factor for T2D. Obesity has increased rapidly in 
a number of populations in recent years because of an interaction between genetic and 
environmental factors (Steyn et al., 2004). In urban population of Pakistan obesity 
was reported as 46% and 68% in males and females respectively (Basit et al., 2005; 
Basit and Shera, 2008). It was higher in age group of 45–54 years in women and 
lowest in men of age group 55–64 years (Gandapur et al., 2006; Jafar et al., 2006; 
Ansari, 2009). Males with the Waist Circumference (WC) greater than 100 cm (40 
inches) and for the female WC greater than 87.5 cm (35 inches) were known to be 
obese. Obesity in females was presented as a relative high risk for diabetes in 
comparison to males (Jafar et al., 2006; Samad et al., 2007; Humayun and Shah, 
2010). There was a statistically significant decrease in insulin resistance and insulin 
sensitivity as Body Mass Index (BMI) increased. Fasting and 2-h glucose from oral 
glucose tolerance tests increased as BMI increased incrementally from below 20 to 
above 30 (Janus, 2004). Urban lifestyles, including rich diet and sedentary habits 
promote further obesity, insulin resistance and T2D (Yajnik, 2004). A study reported 
that the onset of T2D is low in British born women as compared to immigrant British 
born Pakistani females due to lower waist to hip ratio (Pollard et al., 2008). Asians in 
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comparison to Europeans developed diabetes at younger ages and at lower value of 
BMI ≤ 25 (Chan et al., 2009).  
1.5.2 Physical activity 
A significant role may be played by the physical activity in the prevention of 
T2D (Ansari et al., 2009). It’s an evident that hard physical work reduces the 
incidence of the disease. In urban lifestyle usually peoples are involved in official jobs 
or business due to which they become less active than the rural community. They 
have a sedentary life style particularly television watching and surfing the internet 
that’s the reason for higher BMI. The exercises like stair climbing and cycling were 
reported to reduce the risk of T2D (Khan and Ahmad, 1994a, Khan and Ahmad 
1994b; Khan et al., 1999a). The hard physical activity in the rural or mountains areas 
may be the reason for the less occurrence of the disease (Danish et al., 2002). So there 
is a low prevalence of the T2D in Peshawar and Mardan cities (3.57% and 3.53%) of 
Khyber Pakhtunkhwa (Khan et al., 1993a). Physical activity has an important role in 
prevention or delay in onset of T2D in the individuals who were at risk and both can 
act directly by reducing insulin resistance, improving insulin sensitivity which caused 
changes in body mass composition (Boule et al., 2001; Hamman et al., 2006; Kay and 
Fiatarone, 2006). Television watching was identified as a marker for the sedentary 
lifestyle and reported to be positively associated with the onset of diabetes risk in both 
genders (Hu et al., 2002; Hu and Willet, 2003; Krishnan et al., 2009).  
1.5.3  Nutrition 
National nutrition survey indicated that there was higher in quantity of 
saturated fats, carbohydrates, low quantity of proteins, a very less intake of fruits and 
vegetables included in the diet plan of most Pakistanis (National Institute of Health, 
1988). In urban residents are economically sound in comparison to rural areas and 
take rich diet like which are high in fats, sugars and bakery products (Khan and 
Ahmad, 1994a, Khan and Ahmad, 1994b; Danish et al., 2002). Use of too many 
carbohydrates in diet causes the risk of developing diabetes due to which insulin 
resistance takes place and oxidative stress is produced by the lower intake of vitamins 
and minerals (Afridi et al., 2008; Kazi et al., 2008; Jawa et al., 2010). The risk of 
toxicity development from certain minerals was higher (Afridi et al., 2008a) among 
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diabetics in comparison to non-diabetics (Ahmad et al., 2003; Hashim et al., 2006; 
Bansilal et al., 2007). Excessive use of absorbable carbohydrates (e.g., sucrose, 
glucose) in beverages and sugar-sweetened enhanced a Glycemic index, resulted the 
increase of glucose level in blood as well as insulin levels. A diet with high Glycemic 
index that increased  the demand of insulin and may it lead to exhaustion of 
pancreatic b-cells for long run, it had been implicated to increase the risk of 
developing T2D (Hu and Willett, 2002). In South Asia, animal and vegetable ghee has 
been extensively used for cooking containing a high content of unsaturated fat “trans 
fats”. Such as common vegetable ghee in Pakistan (Dalda) contains high contents of 
trans fats up to 50% (Popkin, 2001). Intake of trans fats was reported as the reason of 
diabetes by causing insulin resistance (Mozaffarian et al., 2004). 
1.5.4 Smoking 
Many studies had depicted the association of smoking with incidences of 
glucose intolerance or abnormalities, suggested that the active smoking can 
independently impacted on impaired fasting of glucose as well as associated with T2D 
development (Willi et al., 2007). An association has been reported between T2D 
onset and active smoking (Hensrud, 2001). There were 26% of Pakistani immigrants 
men and 43% of indigenous diabetic population used to of smoking in the general 
population (The Stationery Office, London, 2001; Naheed et al., 2003). 
1.5.5 Depression and hypertension  
Depression is a common health issue, acts as an independent risk factor for 
T2D and co-exists with diabetes. The reported prevalence of depression in diabetics 
was higher as compared to non-diabetics. It was more common in the age of 40 years 
and almost one out of seven diabetics was depressed and females were reported to be 
more depressed than males in urban population (Zahid et al., 2008; Faisal et al., 
2010). Hypertension is strongly associated with the onset of T2D and more than half 
of diabetic population was hypertensive (Basit et al., 2004; Shera et al., 2010). In a 
semi urban area, 12.9% subjects were hypertensive among the diabetics (Basit et al., 
2002; Shera et al., 2007). Pakistani women have high blood pressure and the risk of 
hypertension in relation to T2D was 0.35 and 0.65 times in female population of 
urban and rural areas respectively (Rehman et al., 2004; Samad et al., 2007).  
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1.5.6 Lack of education and awareness 
A health survey showed that, diabetes prevail 2-folds more in population with 
education less than high school compared to graduation or more (Tang et al., 2003) . 
It was suggested that attainment of education promote awareness and care about one’s 
own health which influence the individual’s ability to adopt a healthy life style by 
avoiding risk factors of diabetes. Low education was reported as an important T2D 
predictor (Josepha, 2010). Diabetes prevalence was higher in low educated (low 
income) population of Italy attributed to physical inactivity and obesity that were 
depicted as the strong risk factors for T2D (Gnavi et al., 2008). Dasgupta et al. 
(2010), also reported the risk of development of T2D was higher in the least educated 
individuals who were obese and inactive compared to highly educated population.   
During the survey about diabetes awareness gaps were identified in the 
management of T2D by family practitioners and the patients, many patients had poor 
glycemic control (Dhanani et al., 2008). Diabetic patients in the rural areas were far 
less aware about T2D management and complications (Sabri et al., 2007). It was 
reported in a survey that diabetes leads to different complications, so 13% knew about 
cardiac diseases, 13.7% knew about neurological complications, 51.4% were aware of 
hypoglycemia and about 29.3% respondents had good knowledge about foot care. 
Majority (97.4%) of the diabetics were only aware of diet management (Hasnain and 
sheikh, 2009; Mumtaz et al., 2009). Opportunities for primary prevention of diabetes 
are now available in country (Hussain et al., 2007; Ahmad et al., 2010) but still 
diabetes care practices are observed to be inadequate (Akhter et al., 2007). Many 
patients do not receive optimal diabetes care where as the better care standards are 
provided in private health sector clinics, so there is a need for overall improvement in 
the quality of diabetes care system (Azam et al., 2010). It was suggested that 
prevention of T2D requires a reliable system not only to collect local data but also to 
assess and monitor the situation in order to design evidence based culturally 
appropriate diabetes management guidelines. In Pakistan, lack of surveillance and 
diabetes research at national level has been reported as a basic hindrance to control 
the epidemic of T2D (Afridi et al., 2003; Habib et al., 2003; Hasan et al., 2004; Adil 
et al., 2005; Rafique et al., 2006; Ulvi et al., 2009). 
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Figure 1.2 Pathogenesis of T2D; an effect of genetics and environment on diabetes 
development through insulin resistance and β- Cell failure (FFA: Free Fatty 
Acids) 
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1.6 Genetics of T2D 
Different studies described the role of genetics in development of T2D in 
various populations. A number of prevalence and genetic studies revealed that the 
individuals with first degree relatives’ positive family history are at high risk of T2D 
and chances of getting diabetes in inheritance increased when parents are diabetic 
(James et al., 2000; Janghorban and Amini, 2007). Until 2007 the progress in finding 
genes responsible for the genetic predisposition of diabetes and studies were primarily 
done by investigating biological candidate genes thought to be involved in disease 
pathogenesis or by family-based linkage analysis. Only a few candidate genes 
associated with T2D have since been widely replicated in large-scale studies (Grarup, 
2009). 
1.6.1 Single nucleotide polymorphisms 
“Inheritance of a character controlled by a single gene locus with two alleles 
in which the least common allele has a frequency of about 1% or greater” known as 
Single nucleotide polymorphism (SNPs). Mostly variations seen in sequence of DNA 
were stable and in the form of SNPs, variable tandem repeats and insertion/deletion 
(Vasudevan, 2009). Variation of a single nucleotide T/A/G/C can alter the gene 
sequence. This type of variations occurs in about 1 in 1000 of bases in coding or 
regulatory region. In every gene (exons or coding region) there was an average of 4 to 
8 SNPs occurring in the upstream regulatory regions. Each person would be 
heterozygous for 24,000 to 40,000 amino acid altering substitutions (Lele et al., 
2003). The genetic polymorphisms are integral to the development of genetic markers 
to identify the individuals at risk of developing the diseases. To identify the common 
disease susceptibility loci, many studies encompassing genome-wide association 
mapping, linkage, candidate gene association (Krushkal et al., 1999). Genetic 
variations like SNPs and different specific allelic combinations are denoted as 
haplotypes. Ninety present of sequence variations in humans are contributed by SNP’s 
and they are found to be linked with onset of different diseases (Alfredo et al., 2007).  
The advancement in research has lowered the technical hurdles by sequencing 
and it made possible the detection of variations in DNA in the studied genes. Genetic 
variations were firstly tested by different techniques like restriction fragment length 
polymorphisms (RFLPs), PCR, variable number tandem repeats, microsatellites, 
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insertion/deletion polymorphisms. Most common diseases are complex genetic traits, 
with multiple genetic as well as environmental components contributing to 
susceptibility and the genetic variations found to be linked with different diseases 
(Hirschhorn et al., 2002; Lango and Weedon, 2008). Polygenic diseases are inherited 
in families with complex patterns and the common and rare genetic variants are linked 
to genetic disease (Reich and Lander, 2001; Terwilliger et al., 2002; Pritchard and 
Cox, 2002).  
1.6.2 Candidate and susceptible genes  
Glucose uptake utilized by muscles and adipose tissue; this uptake is 
controlled by short term as well as long term effects of enzymes involved in lipid 
metabolism, glycogen synthesis and glycolytic pathway (Heesom et al. 1997). The 
risk for onset of T2D increased 2-6 times with positive family history (Steyn et al., 
2004). Insulin activity depends upon interactions between different genes (Gerich, 
1998; Valsania and Micossi 1994). Association of genes with T2D was studied in 
different populations and 40 genetic loci were found associated (Ng MC et al., 2008; 
Wu et al., 2008, McCarthy, 2010). Figure 1.3 representing the genes replicated in 
different populations involved in the onset of T2D and insulin resistance along their 
biological functions (Wolfs et al., 2009). Guanine Nucleotide Binding Protein, 
subunit β3, known as the protein encoded by the gene GNB3 in human. This gene 
involved in integrating the modulation of signaling pathway between effectors and 
receptors. GNB3 with SNP C825 can cause insulin resistance in muscle and fat cells 
(Chandrasekaran et al., 2012). The peroxisome proliferator-activated receptors 
(PPARG) belong to the superfamily of nuclear hormone receptor. The PPARG located 
on chromosome 3p25 encoding a nuclear transcription factor which involved in the 
expression of a number of genes. The association between the Pro12Ala variant 
(rs1801282) and T2D was the focus of several studies (Gouda et al., 2010). The 
genetic variations in PPARG and ADIPOQ loci contribute to the risk of T2D 
development in Indian Sikhs (Sangheraa et al., 2010). Genatic polymorphism from 
substitution of proline-alanine (Pro12Ala) at exonic region was associated 
inconsistently against T2D protection. The SNP re1282180 also caused insulin 
resistance, insulin signaling and ultimately development of T2D (Douglas et al., 2001; 
Memisoglu et al., 2003). 
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Figure 1.3 Genes (Genetics) involved in pathogenesis of T2D and are grouped on the basis 
of their biological functions; the 1st group containing genes KCNJ11 (Potassium 
inwardly-rectifying channel, subfamily J, member 11), KCNQ1 (Potassium 
voltage-gated channel, KQT-like subfamily, member 1), ABCC8 (Sulfonylurea 
Receptor) and SLC30A8 (homeostasis of zinc ions); Genes in the 2nd group were 
TCF7L2 (Transcription Factor 7 like 2), TCF1 (Transcription Factor 1), TCF2 
(Transcription Factor 2), HHEX (Hematopoietically Expressed Homeobox) / IDE 
(Insulin Degrading Enzyme), IGF2BP2 (Insulin-like growth factor 2 mRNA-
binding protein 2), CDKAL1 (CDK5 regulatory subunit associated protein 1-like 
1), NEUROD1 (Neuronal Differentiation 1), PDX1 (Pancreatic-duodenal 
Homeobox 1) and NOTCH2 (Notch homolog 2) play a role in the development 
and growth of pancreas; 3rd group of genes JAZF1 (Juxtaposed with Another Zinc 
Finger Protein 1) and TCF2 were involved in the cell cycle regulation; CDKN2A 
(cyclin-dependent kinase inhibitor 2A) and CDC123 (Cell Division Cycle protein 
123 homolog) have a role in the cell cycle. THADA (Thyroid Adenoma 
Associated) and WFS1 (Wolfram Syndrome 1) are thought to be involved in the 
apoptosis of β-cells. Genes involved in the cell cycle and apoptosis of β-cells 
might play a role in diabetes (Wolfs et al., 2009).   
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A common polymorphism in ADRB3 gene has been identified occurring in the 
first intracellular loop of the receptor which is characterized by an amino acid 
substitution of tryptophan by arginine at position 64 (Trp64Arg) (Walston et al., 
1995). The gene ADRB3 play a role in fat metabolism it was found that it may be 
influences the accumulation of fats in body. This receptor expressed in adipose tissue 
and mediates the rate of lipolysis in response to catecholamine and chemical agents 
(Braxton et al., 1999). Natriuretic Peptide Precursor A gene (NPPA; chromosome 
location 1p36.21) in few studies revealed controversial findings on the association 
between polymorphisms within the NPPA gene and hypertension (Conen et al., 2007). 
A study was done for SNPs in TCF7L2 by the development of high-density arrays that 
permit the genotyping of hundreds of thousands of polymorphisms. There were 
392,935 SNPs in French case–control cohort. Four loci were identified from TCF7L2 
containing variants that confer T2D risk. These loci include a non-synonymous 
polymorphism in the SLC30A8 (zinc transporter gene) which is expressed exclusively 
in insulin-producing b-cells (Sladek et al., 2007). The CDKAL1 and HHEX/IDE 
diabetes-associated genes were found to be involved in decreasing pancreatic beta-cell 
function, including decreased beta-cell glucose sensitivity that directly relates to 
insulin secretion (Pascoe et al., 2007). It was revealed that TT genotype in rs7903146 
was playing a role in progression of impaired glucose tolerance to diabetes as 
compared to CC homozygotes (P < 0.001). The TT genotype was associated with 
decreased insulin secretion but not increased insulin resistance. Common variants in 
TCF7L2 seem to be associated with an increased risk of diabetes. The risk-conferring 
genotypes were associated with impaired beta-cell function and did not play any role 
in resistance of insulin (Florez et al., 2006). Qi et al. (2006), reported that highly 
circulating levels of the Interleukin-6 (IL-6) were associated with the insulin 
resistance and predictted a greater risk for the development of type 2 diabetes.  
Four single nucleotide polymorphisms (SNPs, rs2237892, rs2237895, 
rs2237897, rs2283228) in KCNQ1 were reported as associated with T2D in different 
ancestral groups. It was investigated that these four genetic markers found as 
determinants for T2D in a Chinese population. Cases and controls were genotyped for 
4 SNPs by using the ligase detection reaction method. The three genotypes (AA, AC 
CC) were present in rs2283228 and rs2237895 whereas the three genotypes (CC, CT, 
TT) were present in rs2237897 and rs2237892. No differences were found in 
15 
 
 
genotype distribution and allele frequencies of these 4 SNPs between subjects with 
and without type 2 diabetes (Chen et al., 2010). Polymorphism in WFS1 gene caused 
the progressive loss of pancreatic β-cells and sensory neurons. There was an Impact of 
variants in this gene on monogenic form of diabetes and considered as a candidate 
gene for T2D (Chistiakov et al., 2010). Gene POU2F1 also known as octamer-
binding transcription factor-1 (OCT-1) which plays role in the regulation of genes 
related to inflammation and cell cycles. It’s located on 1q24 chromosome and 
depicted a linkage with T2D in in Hong Kong Chinese by using two independent 
cohorts (Ng et al., 2010). 
Inherited variations have been identified from studies of monogenic diabetes 
and provided insights into Beta-cell physiology, insulin release and the action of 
insulin on target cells (Moore and Florez, 2008). Wu et al. (2008), reported significant 
association of SNPs in IGF2BP2 (P=0.014) and SLC30A8 (P = 0.033) with the onset 
of T2D. Each additional risk allele from CDKAL1-rs9465871, CDKN2A/B-
rs10811661, IGF2BP2-rs4402960 and SLC30A8-rs13266634 increased the risk for 
T2D by 1.24-fold. Significant association was observed in the HHEX/IDE SNPs in 
individuals from Shanghai only (P = 0.013) but not in those from Beijing (P = 0.33). 
Gene KCNQ1 was associated with a 20–30% increased risk of diabetes in several 
Asian populations but rare in Caucasians (Unoki et al., 2008; Yasuda et al., 2008). 
The strong association of FTO variants with diabetes in South Asian (Indians) was 
reported but suggested the association of FTO with diabetes in them might operate 
through other mechanisms instead of obesity. It’s a fundamental difference between 
Indians and Europeans in the mechanisms linking body size with T2D. There was a 
strong association of the minor allele A at rs9939609 with disease (P = 3×10-5). The 
variant was also associated with BMI but this appeared to be a weaker association 
than the previously reported effect in Europeans (Yajnik et al., 2009). Rees et al. 
(2011), studied the association of genetic polymorphism in few genes (HHEX/IDE 
and KCNQ1) in south Asians and the Pakistani population was included from AJK 
(Azad Jammu Kashmir) and immigrant Pakistanis. 
Pakistan is a developing south Asian country facing the problem of T2D and 
its complications at its peak. The population of Pakistan consists of vast heterogeneity 
due to diverse geographical area and ethnic groups with cultural as well as linguistic 
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variations. Pakistanis are more vulnerable to T2D because of rapid urbanization, 
susceptible life style and cousin marriages. Diversity within our population depicted 
different genetic makeup in relevance to Europeans and Americans. There is no study 
available on selected genes in our population and which few studies are done that are 
too less to represent diabetes scenario in Pakistan. In this study the main risk factors 
were also identified e.g. positive family history, hypertension, obesity and 
overweight. There is no curative treatment for the disease throughout the world, it can 
only be controlled. Moreover cousin and cast to cast marriages are very common 
among our nation; it’s a key reason to make a diabetes susceptible gene pool. So the 
study was designed to identify the SNPs in candidate genes and to provide data on 
susceptible gene. The analysis of genetic risk factors will determine the earlier 
prediction of diabetes for the communities at risk. The study will be used to reduce 
the onset or delay of disease in the individuals at risk by change in life style or 
adopting preventive measures that ultimately lead to improve the quality of life and 
reduce expenditures to control diabetes. Identification of T2D susceptible genes will 
be helpful for the understanding the pathophysiology of diabetes. This study was an 
attempt to reveal the presence of SNPs in the candidate genes that may play a role in 
the onset of T2D. 
1.7 Aims and Objectives 
The aims and objectives of this study are 
 To determine the risk factors and economic burden of T2D in central Punjab, 
Pakistan. 
 To identify the SNPs in candidate genes associated with pathogenesis or 
predisposition of diabetes. 
 To compare the identified SNPs with genetic markers of Europeans, 
Americans, Africans and East Asian ethnicity. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Diabetes  
Type 2 diabetes (T2D) accounts for 90% of all forms of diabetes and it’s a 
complex polygenic disease manifested in a dysregulation of insulin secretion. 
Environmental influences and complex genetic traits contribute to the pathogenesis of all 
types of diabetes (Habener and Stoffers, 1998). Type 2 Diabetes (T2D) causes defects in 
glucose metabolism due to insulin secretion, action or may be due to both (Pozzili and 
Di, 2001; Borroso et al., 2003; Khan and Safdar, 2003). Diabetes was reported as the 
disease with the high level of blood sugar and a life lasting metabolic Syndrome. 
Basically diabetes exist in two distinct forms, type 1 that is insulin dependent caused by 
functional loss of pancreatic beta cells and type 2 is non-insulin dependent can also be 
caused by decrease in insulin sensitivity within the peripheral tissues (Carpenter, 2008). 
2.2 Prevalence of T2D 
It was stated by World Health Organization (WHO) that till 2025, 300 million 
individuals will be affected by diabetes worldwide (King et al., 1998). Evidences were 
indicating the dramatic increases in T2D in the developing countries of Africa, Asia and 
South America in future (Zimmet et al., 2001). The worldwide prevalence of diabetes 
was predicted to increase from 2.8% in 2000 to 4.4% in 2030 with over 350 million 
affected people (Wild et al., 2004). According to International Diabetes Federation (IDF), 
diabetes affected approximately 285 million of people throughout the world and it’s 
expected is up to 438 million till 2030. Two-thirds of diabetes cases are reported from 
countries with low- to middle-income (IDF, 2011).  
2.3 Economic burden of diabetes 
The American Diabetes Association (ADA) in 1997 estimated the direct medical 
cost due to diabetes, complications and indirect social expenditures of approximately 98 
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billion US$ (ADA, 1998). A study in eight European countries (United Kingdom, 
Sweden, Spain, Germany, France, Italy, Netherland and Belgium) estimated the average 
annual cost for diabetes treatment per patient was 2834 Euros. The major proportion of 
the cost was going to hospitalization. Antidiabetic drugs were accounts only 7% of the 
health care budget (Jonsson et al., 2002). Direct medical and indirect expenditures 
reported in 2002 were 132 billion US$. Direct medical cost was 91.8 billion US$ and 
23.2 billion US$ for care of diabetes, 24.6 billion US$ for chronic diabetes complications 
and 44.1 billion US$ were for general medical conditions. ADA reported the medical 
expenditures in different races and compares the diabetics with non-diabetics. They 
concluded that individuals with diabetes were with expenditures 2.4 folds higher than the 
same group in the absence of diabetes (ADA, 2003). Diabetes major complications like 
acute myocardial infarction cause a greater financial burden on society than early stage 
complications e.g microalbuminuria. So the complications which are relatively low in 
start like microalbuminuria can progress to more serious stages such as end-stage renal 
disease. Microvascular and macrovascular complication costs should also be included in 
economic analysis of diabetes (O'Brien et al., 2003). A study on cost of illness in six 
outpatient clinics of Karachi, Pakistan was revealed that the increase in age, 
complications and longer diabetes duration significantly increase the economic burden on 
society (P < 0.001) (Khowaja et al., 2007). Kirigia et al. (2009), recorded   2 million 
cases of diabetes in countries of the African Region in 2000 resulted in a total economic 
loss of internationally 25.51 billion US$. According to this research the economic burden 
of diabetes and diabetes care at national level in U.S was reached to 218 billion US$ in 
2007. The estimated cost also includes the medical expenditures (153 billion$) as well as 
reduced productivity ($65 billion). The calculated average cost/case was 2,864 US$ for 
undiagnosed diabetes and 9,975 US$ for diagnosed diabetes whereas 443 US$ was for 
pre-diabetes (Dall et al., 2010). Bi et al. (2012), reported a heavy socioeconomic burden 
of T2D on public health budget.  
2.4 Risk factors of T2D 
The previous studies reported the association of genetic polymorphism with the 
onset of T2D. It was suggested that the onset of T2D inherited with the positive family 
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history and environmental factors may also be involved to express the genetic factors 
(Simmons et al., 1992). Horikawa et al. (2000), reported T2D as the most common form 
of diabetes worldwide, affecting approximately 4% of the world's adult population. It’s 
multifactorial in origin with both genetic and environmental factors contributing to its 
development. A genome-wide screen of genes for T2D carried out in Mexican Americans 
localized a susceptible gene on chromosome 2 designated as NIDDM1.  
2.5 Environmental factors   
A follow-up of 16 years has given 3300 of newly diagnosed cases of diabetes. 
The most important risk factor was higher BMI (Obesity and overweight). Lack of proper 
diet and exercise were making the population at risk. In total diagnosed cases of diabetes 
91% were due to unhealthy lifestyle (Hu et al., 2001).  
Indians had a very high prevalence of diabetes adjusted for age and the risk 
started to increase at very low levels of BMI (Nakagami, 2003). T2D thought to be due to 
environmental factors such as increased availability of food and lack of physical activity 
that acts on genetically susceptible population (Permutt et al., 2005). It was suggested 
that prevalence of both metabolic syndrome and abdominal obesity  increased by 2 folds 
in urban in comparison to rural population (62% vs 36% for obesity and 33% vs 18% for 
Metabolic Syndrome respectively) (Misra et al., 2008). Another cross sectional study 
from the National Health Interview Survey found that women with low education had a 
higher prevalence of diabetes than the highly educated. The association varied by gender 
and ethnicity like Hispanics, Whites and women exhibiting a stronger association 
between education and diabetes than blacks and men (Borrell et al., 2006).  
2.6 Genetic factors 
It was reported that only 5%–10% of T2D cases are due to single gene defects 
otherwise in most of cases a number of genes interact for the diabetes onset (Ledermann, 
1995; Fajans et al., 2001; Rahilly et al., 2005; Janssen et al., 2007). Genetic 
polymorphism is identified as a strong risk factor for the onset of the disease in Pakistani 
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population; T2D is a polygenic trait, inherited with the positive family history (Shera et 
al., 2006).  
Recent data suggested that common variation in the TCF7L2 gene associated with 
T2D. All SNPs in this gene showed strong associations with diabetes in the case-control 
analysis (Groves et al., 2006). The TCF7L2 was observed as a diabetes susceptible gene 
in American Africans (Elbein, 2007) and differences in allele frequencies of risk 
polymorphisms between ethnicities have been reported (Chandalia, et al., 2007). Despite 
most of the effect sizes being similar between Asians and Europeans in the Meta analysis; 
but the ethnic differences in risk allele frequencies in most of these genes lead to variable 
attributable risks in Hong Kong and Korean population (Maggie et al., 2008). 
Association of seven SNPs with T2D from gene PPARG was studied and three SNPs 
(rs1152003, rs1801282 and rs17036314) were associated with the risk of development of 
T2D. Increased physical activity decreased the risk allele’s rs17036314 and rs1801282 
effect in diabetes onset. The role of rs1152003 was modified by other lifestyle changes or 
the lifestyle intervention as a whole (Kilpeläinen et al., 2008). 
This study supported the role of seven SNPs in the onset of diabetes in the 
Chinese Han population of Beijing. The risk allele from CDKAL1-rs10946398 (P = 
0.0008), IGF2BP2-rs44029601.26 (P = 0.003), SLC30A8-rs13266634 (P = 0.009), 
CDKN2A/B-rs10811661 (P = 0.005), HHEX-rs5015480 (P = 0.03), KCNQ1-rs2237892 
(P = 1.0 × 10-4) and FTO-rs8050136 (P = 0.046) were studied after adjustment for age, 
gender and BMI in Chinese Han population of Beijing. Moreover the relationship 
between FTO-rs8050136 and BMI together with the effect of CDKAL1-rs10946398 on 
beta cell function was observed (Han et al., 2010). Genetic variants of WFS1 contribute 
to the pathogenesis of T2D through impaired insulin response to glucose stimulation and 
altered β-cell function (Chistiakov et al., 2010). The allele G of rs7923837 (locus: 
HHEX-IDE) was associated with higher pediatric BMI in both the discovery (P _ 0.0013 
and survived correction for 20 tests) and replication (P _ 0.023) sets. Association was not 
detected with any other known type 2 diabetes loci uncovered to date through GWAS 
except for the well-established FTO (Zhao et al., 2010). A study of French population 
showed an association between the G-allele of rs10010131 and incidences of T2D (HR 
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1.34, 95% CI 1.08–1.70, P = 0.007). Similar results were observed for the G-allele of 
rs1801213 and the allele A of rs734312. The GGA haplotype was associated with an 
increased risk of diabetes as compared with the ACG haplotype (HR 1.26, 95% CI 1.04–
1.42, P = 0.02). The most frequent haplotype at the haplotype block containing the WFS1 
gene modulated insulin secretion and was increasing the risk of T2D development 
(Cheurfa et al., 2011). The association of genes LPIN1 and PPARG polymorphisms with 
HDL (High Density Lipoprotein), values of insulin, LDL (Low density Lipoprotein) and 
total cholesterol. These genes played a role in pathogenesis of T2D and metabolic 
syndrome lipid metabolism (Bego et al., 2011). Genome scan studies in Europeans had 
identified association of a new signal in KCNQ1 gene with diabetes at 11th intron of it. 
The SNPs in KCNQ1 were significantly associated with T2D in Indian population. 
Haplotypes from this gene suggested its association with the risk of diabetes derived from 
C allele of rs2237895 and G allele of rs231362 (Been et al., 2011). 
Polymorphism in rs4994 of ADRB3 gene was associated with T2D (P = 0.001) 
(Cruz et al., 2010). Under an additive genetic model the C allele of ADRB3-rs4994, C 
allele of ENPP1-rs1044498 and allele A of PPARG C1A-rs8192678 increase the risk of 
type 2 diabetes in the Han Chinese population (Jing et al., 2012). In the case-control 
analysis PPARG rs1801282 (Pro12Ala), ADIPOQ rs1063539 and HNF4A rs1884614 
were associated with T2D (P (allelic) < 0.05). Joint analysis of rs1801282-C, rs1063539-
G and rs1884614-T risk alleles showed an additive dosage effect (P for trend = 0.001). 
Moreover, carriers with two PPARG rs1801282-C risk alleles were associated with an 
increased risk of coronary heart diseases (P - 0.045) in T2D patients in the prospective 
analysis. Genetic variants of PPARG, ADIPOQ and HNF4A were individually as well as 
jointly were associated with T2D in Hong Kong Chinese (Ho et al., 2012). It was 
reported that SNPs in KCNQ1 were significantly associated with T2D in Dutch 
population and a strongest association of rs151290 was reported (OR 1.20, 95% CI 1.07–
1.35, P = 0.002). In addition the SNP rs2237892 with C-allele was associated with higher 
Low Density Lipoprotein (LDL) and total cholesterol levels (P = 0.015 and 0.003 
respectively). There was no evidence of this gene with complications of diabetes (Vliet-
Ostaptchouk1 et al., 2012). Cycklin-dependent kinase 5 regulatory subunit-associated 
protein 1-like 1 (CDKAL1) was reported to be associated with diabetes in different ethnic 
22 
 
 
groups however there were some contradictory results. It was found that significant 
association of rs7754840, rs7756992 and rs10946398 within CDKAL1 with diabetes (OR 
= 1.14, 95%CI = 1.06-1.24, P = 0.001, OR = 1.15, 95% CI = 1.07-1.23, P < 0.0001 and 
OR = 1.12, 95%CI = 1.07-1.18, P < 0.0001 respectively) (Dehwah et al., 2010). 
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Table. 2.1 Frequently Replicated SNPs in different Population Involved in 
Pathogenesis of Diabetes  
Gene SNP 
(rs No.) 
Function  Population References 
TCF7L2 rs7903146 
 
 
 
 
rs12255372 
rs11196205 
rs290487 
rs11196218 
rs7903146 
It plays role in 
adipogenesis, 
development of 
pancreatic islet, survival 
of beta-cells and insulin 
secretory granules  
Caucasian, 
Americans, 
Indian, 
Pakistani, 
 
East Asian,  
 
 
 
 
Hoek et al., 2008 
Lewis et al., 2008 
Mukhopadhgaya et 
al., 2010 
Rees et al., 2011 
 
Luo et al., 2009 
 
 
 
KCNQ1 rs2074196 
rs2237892 
rs2237895 
rs2283228 
rs2237897 
rs151290 
rs2237892 
rs2237895 
rs231362 
It  encodes for a voltage-
gated potassium channel 
which is highly 
expressed in pancreas, 
cardiac muscles, kidney 
and intestine 
Japanese  
and Dutch  
 
 
 
 
US and Indian 
 
Jonsson et al., 2009 
Vliet-ostaptchouk et 
al., 2012 
 
 
Been et al., 2011 
 
Rees et al., 2011 
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Table 2.1 continue 
 
WFS1 rs10010131 
rs1801213/r
s7672995 
rs734312 
rs10010131 
rs6446482 
rs734312 
rs752854 
rs10010131 
rs1412829 
It encodes a protein 
which is important for 
insulin-producing beta 
cell survival and function 
in the pancreas. 
 
French 
 
 
Ashkenazi 
(Jews) 
Russian  
 
 
Caucasian 
Cheurfa et al., 2011 
 
 
Sandhu et al., 2007 
Chistikov et al., 
2010 
 
 
Hoek et al., 2008 
PPARG rs1801282 
 
 
 
 
 
rs1152003 
rs17036314 
rs1801282 
Its encoded protein 
involved in the formation 
of fat storage cells and  
can cause dysregulation 
of fat metabolism, it 
involved in the 
development of insulin 
resistance—the decrease 
in insulin response after 
chronic consumption of 
sugar 
Asian Indian 
Sikhs 
Chinese 
French 
Caucasian 
Finnish 
 
 
Sanghera et al., 
2010 
 
Hu et al., 2009 
Jaziri et al., 2006 
 
Kilpelainen et al., 
2008 
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Table 2.1 continue 
 
HHEX/I
DE 
rs1111875 
 
rs1111875 
rs5015480 
rs7923837 
rs792383 
rs1111857 
rs5015480 
It plays a role in early 
development of the liver 
and pancreas. It has been 
shown to be associated 
with decreased insulin-
producing beta cell 
function in the pancreas, 
resulting in decreased 
beta cell glucose 
sensitivity and 30-minute 
insulin response. 
European 
Americans 
 
 
Han Chinese 
Pascoe et al., 2007 
Lewis et al., 2008 
 
 
Wu et al., 2008 
FTO rs9939609 
 
rs8050136 
rs9939609 
rs7191344 
It increases body-fat and 
causes obesity 
French 
Pakistani 
Caucasian 
South Asian  
Indians  
Legry et al., 2009 
Rees et al., 2011 
Hoek et al., 2008 
Yajnik et al., 2009 
 
CDKAL1 rs10946398 
 
rs7754840 
rs10946398 
rs4712523 
rs10946398 
rs7756840 
rs7756992 
It can cause insulin 
resistance which causes 
decrease in insulin 
response after chronic 
consumption of sugar. 
European  
Han Chinese 
Americans 
 
Pima Indian 
 
Pascoe et al., 2007 
Wen et al., 2010 
Lewis et al., 2008 
 
Rong et al., 2009 
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Table 2.1 continue 
 
CDKN2A
/B 
rs10811661 
 
 
rs564398 
rs10811661 
CDKN2A and CDKN2B 
are closely related genes 
and they control the 
growth of insulin-
producing beta cells in 
the pancreas.  
Chinese 
Pakistani 
Indian  
Americans 
Han et al., 2010 
Rees et al., 2011 
Chauhan et al., 
2010 
Lewis et al., 2008 
  
SLC30A8 rs13266634 
 
 
 
 
It transports zinc into 
insulin-secreting 
pancreatic beta cells. 
Zinc plays a role in 
insulin production, 
storage, and secretion. 
Swedish and 
Finnish 
Caucasian 
Americans 
Lyssenko et al., 
2008 
 
Hoek et al., 2008 
Lewis et al., 2008 
KCNJ11 rs5219 It encodes a protein that 
acts as a gatekeeper for 
insulin release. Glucose 
from a sugary meal 
activates this gatekeeper 
protein, which then sets 
off a chain of events that 
ultimately results in 
insulin release from 
pancreatic beta cells. 
Swedish and 
Finnish 
Chinese  
Lyssenko et al., 
2008 
 
Hu et al., 2009 
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CHAPTER 3 
MATERIALS AND METHODS 
3.1 Sampling  
Sampling was carried out in two steps; the initial step was consists of Type 2 
Diabetes (T2D) survey containing risk factors as well as economic burden of disease on 
the society and final step was genetic analysis. 
3.1.1 Subject Selection 
Based upon the Survey Software calculations, using 95% confidence level, 
population of the selected area and confidence interval, a total of 1,000 patients of both 
the sexes were randomly selected for voluntary participation in the present study, after 
getting their informed consent, out of the visitors of the Diabetes centers and outpatient 
Clinics located in urban (Lahore, Rawalpindi/ Islamabad; n = 500) and rural (districts 
Gujrat, Jhelum, Chakwal; n = 300) of northern Punjab (Pakistan) between June 2011 and 
December 2012. The diabetes centers and outpatient clinics, registered with the 
government, were selected to get clinically diagnosed data of the patients to exclude self-
reported cases of diabetes. . Follow up of the 800 initially selected subjects indicated that 
the data on the clinical assessment of diabetes of some of the patients was incomplete or 
clinically ambiguous and hence were excluded from further analysis. Thus, a total of 591 
T2D patients (women = 358, men = 233) were retained for further studies.  There was a 
low level of response from the patients due to lack of awareness and education. Some of 
the patients provided incomplete information and even avoid interviews. 
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Sampling 
Blood Sampling (Cases=300, 
Control= 170 
History & 
Records (n=591) 
DNA Extraction Age, Age of diagnosis, Family 
history, depression, Hypertension, 
Disease management cost, Duration 
of diabetes, Complication etc 
SNPs Selection 
Primer Designing 
PCR for Optimization 
of Primers 
DNA Sequencing for SNP 
Detection 
Tabulation of Data 
Sequence reading in Chromas 
Program & Tabulation 
Data analysis by Fischer’s and 
Chi square test, & SHEsis test 
for SNPs association with 
T2DM 
 
Statistical Analysis by using, t test, 
chi square, Kruskal Wallace test etc 
Analysis of 
Gene-
Environment 
interaction 
Figure 3.1   Schematic presentation of research layout 
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3.1.2 Data Collection 
Abiding by Helsinki Declaration and Human Studies, a consent performa was 
developed (Annexure I) for the privacy of patients data and approved by the Ethetical 
Committees of the Board of Advance Studies and Research, Government College 
University Lahore (Pakistan) as well as by Diabetes and Endocrinology Centre, Jinnah 
Hospital, Lahore (Pakistan). The pre-informed consent of the individual patient was taken 
and the performa signed by the patients, as an endorsement of their consent as well as to 
ensure privacy policy. Structured interview based upon the questionnaire was conducted 
by the author and responses recorded on the performa in the field to collect data on 
different demographic variables, such as, gender, age, age at diagnosis, family history of 
diabetes and education (illiterate, primary, college and above), job status (jobless, laborer, 
housewives and office/ business), and family income(low = <10,000 PKRs/ month; 
middle 10,000-20,000 PKRs/ month) and high income group ( >20,000 PKRs/ month). 
Height (m) and weight (kg) of each patient was recorded and body mass index (BMI = 
weight in kg/ height in m calculated (Kaisar et al., 2012). At the time of their clinical 
assessment and patients with BMI > 25 kg/ m2 were regarded as overweight (WHO, 
2004). All of the subjects were clinically screened for complications, like, nephropathy, 
retinopathy and cardiovascular diseases, and the patient with one or more of such 
problems were excluded from the study sample. The information about regularity of 
clinical checkup (blood glucose at least twice a month) / treatment (using prescribed oral 
medication/ insulin) of the patient was also recorded. Calculated treatment cost included 
the cost of the medicine (oral medication and insulin) used. The cost of complications 
was based on cost incurred on medicine/ treatment of clinically diagnosed patients with 
complications. All cost was estimated in Pakistani Rupees (PKRs) and converted to US 
dollar at a rate of 90.84 PKRs =1US$.  
3.1.3 Blood Sampling for Genetic Analysis 
A volume of 3-5 ml of venous blood were collected using sterilized plastic 
disposable 5 ml syringe (BD Syringes) from both the T2D patients and non-diabetic 
normal individuals, consented to participate in the study with the help of medical staff. 
30 
 
 
Blood was then transferred to EDTA coated tubes, labeled properly with patient code 
number, date of collection and Centre/Clinic code number, and immediately taken to the 
laboratory (Zoology Department, Government College University, Lahore, Pakistan) in 
ice containers. Blood was then stored at 2-4 oC (Dawlance 9144 M Monogram) till it was 
further processed for DNA extraction (within 6 months). Relevant data of the individual 
was recorded on a separate Performa (Annexure I) following Luna et al. (2001).   
3.2  DNA Extraction 
DNA was extracted using Fermentas Genomic DNA Purification Kit (#K0512). 
For the purpose 200 μl of blood sample was mixed with 400 μl of cell lysis buffer 
(provided in kit # K0512) and the mixture was incubated in water bath (thermostat water 
bath, HH-4, China) at 65 °C for 5 minutes. The mixture was again incubated at 65 °C for 
10 minutes with occasional inverting of the tube. A volume of 600 μl of chloroform 
(Merck, Molecular grade) was then added into the mixture, immediately after the 
incubation; gently emulsified by inverting the tube 3-5 times and centrifuged the sample 
at 10,000 rpm (Eppendorf centrifuge, 5810R, Germany) for 2 minutes. The freshly 
prepared precipitation solution (720 μl of sterile deionized water mixed with 80 μl of 
supplied 10X concentrated precipitation solution) was added into the centrifuged mixture 
and allowed it to precipitate. The upper aqueous phase containing DNA was transferred 
to a new presterilized tube and 800 μl of freshly prepared precipitation solution was 
added. DNA along precipitation solution was mixed gently by several inversions at room 
temperature (20-23 ◦C) for 1-2 minutes and centrifuged at 10,000 rpm (~9400 x g) for 2 
min. Supernatant was removed completely, not allowing it to dry and dissolved DNA 
pellet in 100 μl of sodium chloride (NaCl) solution by gentle vortexing for 3 min. The 
DNA pellet was completely dissolved in 300 μl of cold ethanol (Merck; Molecular grade) 
for precipitation (10 minutes at -20 °C) and DNA spinned down at 10,000 rpm (~9400 x 
g) for 3-4 minutes. Ethanol was removed and washed the DNA pellet once with 70% cold 
ethanol. DNA was dissolved in 100 μl of sterile deionized water by gentle vortexing. The 
presence of extracted DNA was examined by 1 % agarose gel electrophoresis as detail 
procedure given in annexure II (Bio rad) and the concentration was measured by the 
nanodrop (Thermo Scientific Nanodrop, 2000 spectrophotometer). DNA samples were 
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stored at -40 °C (SANYO Biomedical freezer, Model- 05411, Japan) and used for further 
analysis at a later stage.  
3.3  SNPs primer designing 
Selection of Single Nucleotide Polymorphisms (SNPs) was based on the reported 
genetics associations with T2D from HapMap data bank and National Center for 
Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov). The SNPs were 
selected from the genes which were involved in insulin action, production, secretion, or 
having role in the enhancement of risk factors, e.g., obesity, depression and hypertension. 
Some SNPs were selected from the genes, that can cause cardiac and kidney 
complications in T2D patients.  
The NCBI website was used to develop the SNPs 
http://www.ncbi.nlm.nih.gov/snp/. The longer sequence for SNPs was obtained through 
http://genome.ucsc.edu/ and primers were designed from (http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi). Specificity of primers was validated against the human 
genome from NCBI database with BLAST (http://www.ncbi.nlm.nih.gov/BLAST/). 
Forward & reverse primers for 1st and nested PCR were designed (Figure 3.1) for the 30 
selected SNPs (Table 3.1). The two set of primers for each SNP, their annealing 
temperature, PCR products and sequencing primer (forward or reverse) were presented in 
Table 3.2. 
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Find in SNP NCBI (Fasta) 
GCAATAGACCTTATGACACCTAACCAACCCCATTATTTACAATTAAACAGGA
ACAGAGGGAATACTTTATCCAACTCACACAAGCTGCTTTCCTCCCAGATCCAT
GCTTTTTTGCGTTTATTATTTTTTAGAGATGGGGGCTTCACTATGTTGCCCACA
CTGGACTAAAACTCTGGGCCTCAAGTGATTGTCCTGCCTCAGCCTCCTGAATA
GCTGGGACTACAGGGGCATGCCATCACACCTAGTTCATTTCCTCTATTTAAAA
TATACATGGCTTAAACTCCAACTGGGAACCCAAAACATTCATTTGCTAAGAG
TCTGGTGTTCTACCACCTGAACTAGGCTGGCCACAGGAATTATAAAAGCTGA
GAAATTCTTTAATAATAGTAACCAGGCAACA[Y]CATTGAAGGCTCATATGTA
AAAATCCATGCCTTCCTTTCTCCCAATCTCCATTCCCAAACTTAGCCACTGGC
TTCTGGCTGAGGCCTTACGCATACCTCCCGGGGCTTGCACACACCTTCTTCTA
CAGAAGACACACCTTGGGCATATCCTACAGAAGACCAGGCTTCTCTCTGGTC
CTTGGTAGAGGGCTACTTTACTGTAACAGGGCCAGGGTGGAGAGTTCTCTCCT
GAAGCTCCATCCCCTCTATAGGAAATGTGTTGACAATATTCAGAAGAGTAAG
AGGATCAAGACTTCTTTGTGCTCAAATACCACTGTTCTCTTCTCTACCCTGCCC
TAACCAGGAGCTTGTCACCCCAAACTCTGAGGTGATTTATGCCTTAATCAAGC
AAACTTCCCTC 
Find in UCSC 
CACCTTGCATATCTGATTTTGTGGATCATGGGGAAAAACTGCTGATTCCTAGC
AAAACCCATGGCATAGGATAAGTGCACAATAATTTTTTTTTCCTAAATGATTT
AGATGACAGTGACTCATTAAGGGTTTCCTGAGGCCTCCTCAGAGTCGAGAGG
TGGGTGCCTGAAGCCACCCAAAGTCCCTGTCACAGGATGGCTCCCAACGCAC
ACACCACAGGCCTGCCCAGTATGTTCCACTATCTACCCAGTAGAGCCCTGCCC
AGTACGTTCCACTGTCCCTTCCCTAGAAGAGGTGACTGTTGTTCACAGTCCCA
GAAAAGCGGGCTCCCCAAAACAATGCAAGGACCCACCTCTCTCTGAACCTCA
CCCACCCTAGTTTTCCTTTAAAAATCAATTTACAAGAAGATCATGTGAAGGAA
AAGGTTGGGTGATATTCTAACCCAAGTTAGCTGTTTCTCAACCAAGTTCTCTT
TGAAAAATTCAACAACCACCTTTGGGGAATTATTTACAACAGAGGAGTGAGG
ATGGGACCAGGATAGGTATTGCCTATGTTGGTGGAACCAGGGTTTTTTTCCTG
GATTACCAAAGAGATGGTATGCATTGCTCCCAGAAGCTAAATATCTTCAGGC
TTTCAATGGTGGCCTTCACCTGAAAATGTTATCCCTGTTGAAGCTTTCAAGCC
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AGTATTTTCATAAGAACTATATTTTCTTTGGTGAACTGAGGCATTATAATGAT
GACTATACAGGTTCTTGAGTGACTGAAGCCATCATTAGCATTGTCATTATTTT
TGTTTAGTTGCATCTCCATAGCAGCTCACATTCACAATGTGCTTTGCAATTGTT
CCTTAGCAATAGCCCTCACAAGATTCTCAGGAGGAGAGGGTTAATCAGGATT
AACATTTCTGTGTTGCCTAAAGAGGAACCAAGGTAAGCAGAAATGTAGCCAG
TTGGCTGGCATCACTGTTGCTTCAGGATTCATCCTTAGACACCCAAGCTTCTA
CCCTAGTCTGGTGCTACACTTACATTGCTTACATCCAAGTGTGGTTATTTCTGT
GGCTCCTGTTATAACTATTATAGCACCAGGTCTATGACCAGGAGAATTAGACT
GGCATTAAATCAGAATAAGAGATTTTGCACCTGCAATAGACCTTATGACACC
TAACCAACCCCATTATTTACAATTAAACAGGAACAGAGGGAATACTTTATCC
AACTCACACAAGCTGCTTTCCTCCCAGATCCATGCTTTTTTGCGTTTATTATTT
TTTAGAGATGGGGGCTTCACTATGTTGCCCACACTGGACTAAAACTCTGGGCC
TCAAGTGATTGTCCTGCCTCAGCCTCCTGAATAGCTGGGACTACAGGGGCAT
GCCATCACACCTAGTTCATTTCCTCTATTTAAAATATACATGGCTTAAACTCC
AACTGGGAACCCAAAACATTCATTTGCTAAGAGTCTGGTGTTCTACCACCTGA
ACTAGGCTGGCCACAGGAATTATAAAAGCTGAGAAATTCTTTAATAATAGTA
ACCAGGCAACACCATTGAAGGCTCATATGTAAAAATCCATGCCTTCCTTTCTC
CCAATCTCCATTCCCAAACTTAGCCACTGGCTTCTGGCTGAGGCCTTACGCAT
ACCTCCCGGGGCTTGCACACACCTTCTTCTACAGAAGACACACCTTGGGCAT
ATCCTACAGAAGACCAGGCTTCTCTCTGGTCCTTGGTAGAGGGCTACTTTACT
GTAACAGGGCCAGGGTGGAGAGTTCTCTCCTGAAGCTCCATCCCCTCTATAG
GAAATGTGTTGACAATATTCAGAAGAGTAAGAGGATCAAGACTTCTTTGTGC
TCAAATACCACTGTTCTCTTCTCTACCCTGCCCTAACCAGGAGCTTGTCACCC
CAAACTCTGAGGTGATTTATGCCTTAATCAAGCAAACTTCCCTCTTCAGAAAA
GATGGCTCATTTTCCCTCAAAAGTTGCCAGGAGCTGCCAAGTATTCTGCCAAT
TCACCCTGGAGCACAATCAACAAATTCAGCCAGAACACAACTACAGCTACTA
TTAGAACTATTATTATTAATAAATTCCTCTCCAAATCTAGCCCCTTGACTTCG
GATTTCACGATTTCTCCCTTCCTCCTAGAAACTTGATAAGTTTCCCGCGCTTCC
CTTTTTCTAAGA 
Figure 3.2 rs1800587 (SNP from Interleukin gene) the sequences marked yellow represent the 1st PCR 
product while those marked red represents the nested PCR product 
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Table 3.1 SNPs and their gene with chromosomal locations used in the study 
SNPs No. Chromosomal Position Gene rs No. 
S1 4p16 WFS1 734312 
S2 1q24 POU2F1 3767434 
S3 1q24 POU2F1 10918682 
S4 1q24 POU2F1 2146727 
S5 11p15.5 KCNQ1 2237892 
S6 11p15.5 KCNQI 2237895 
S7 11p15.5 KCNQI 234864 
S8 10q25.3 TCF7L2 290481 
S9 10q23.33 HHEX 7923837 
S10 5q11.2 ITGA2 1062535 
S11 11p15.2-p15.1 NELL1 1459865 
S12 11p15.2-p15.1 NELL1 11026146 
S13 10q23-24 IDE 6583813 
S14 10q23-24 IDE 7910977 
S15 14q21.3 CDKL1 7756992 
S16 1p36.21 NPPA 5063 
S17 1p36.21 NPPA 5064 
S18 8p12 ADRB3 4994 
S19 16p12.2 PRKCB1 7404928 
S20 16q21 CETP 1800775 
S21 12p13 GNB3 5443 
S22 6p21 LTA 909253 
S23 8p22 LPL 328 
S24 2q12–21 IL1A 1800587 
S25 2q14 IL1B 1143634 
S26 3p25.2 PPARG 1801282 
S27 4p16.3 ADD1 4961 
S28 7q21.3 PON1 854560 
S29 7p21 IL6 1800796 
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3.4  Primer Optimization 
3.4.1 Gradient PCR 
Amplification of DNA fragment was performed in a 20 μl PCR reaction mixture, 
containing 50-60 ng of genomic DNA. Each primer contained 75 nmol/ L (Invitrogen, 
Honkong) 50 nmol/ L of each deoxyribonucleotide triphosphate (dNTPs: Promega, USA 
U1515), 0.5 mM/L magnesium chloride (MgCl2, Sigma: M2670), 1 U Taq DNA 
polymerase (Amersham Bioscience, Uppsala, Sweden) and genomic DNA 0.6 μl. 
PCR (Applied Biosystem thermal cycler, model# 9902, Singapore) consisted of 
following steps. 
 Initial denaturation at 94 °C for 5 minutes,  
 30 cycles each of 30 seconds at 95 °C,  
 30 seconds at 54-64 °C (gradient PCR),  
 2 minutes at 72 °C, plus a final extension step at 72 °C for 8 minutes  
3.4.1.1 1st PCR (Gradient PCR) Reaction Mixture 
Forward primer                                    6.25 µl (each primer) 
Reverse primer                                     6.25 µl (each primer) 
Master mix              4µl  x 50                200 µl 
Milliq      14.5 µl _________________ 705 µl 
Taq pol                                                 0.3 µl  15 µl 
DNA       0.6 µl                                     30 µl 
  20 µl                                                     1000 µl 
A 96-well PCR plate was used for optimization, where eight set of primers were 
tested at a time. Reaction mixture was prepared in two Eppendorf tubes for 50 wells of 
PCR plate.  The reaction   mixture was loaded to Eppendorf (230 to each eppendorf tube 
and 6.25 µl of each primer F & R). The 20 µl of reaction mixture was loaded in each 
well. PCR plates were covered and spinned for 7 seconds. Gradient PCR program was 
used for primer optimization.   
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a. 
 
 
 
 
b. 
 
 
 
 
c. 
 
Figure 3.3 Representing the PCR plate preparation and sealing (a) 96-well PCR plate (b) 
Loading of samples (c) Sealing of PCR plate after loading reaction mixture 
and primers 
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Gradient 
PCR 
Temp. 
54◦C 56◦C 58◦C 60◦C 62◦C 64◦C 
A(1pp) 1 2 3 4 5 6 7 8 9 10 11 12 
B(2pp) 13 14 15 16 17 18 19 20 21 22 23 24 
C(3pp) 25 26 27 28 29 30 31 32 33 34 35 36 
D(4pp) 37 38 39 40 41 42 43 44 45 46 47 48 
E(5pp) 49 50 51 52 53 54 55 56 57 58 59 60 
F(6pp) 61 62 63 64 65 66 67 68 69 70 71 72 
G(7pp) 73 74 75 76 77 78 79 80 81 82 83 84 
H(8pp) 85 86 87 88 89 90 91 92 93 94 95 96 
       Pp: pair of primers 
Figure 3.4 Template for optimization of primers in a 96-well PCR plate showed 
gradient PCR at six different temperatures and loading of pair of primers 
(Eight pair of primers can be tested in each plate at a time) 
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3.4.2 Purification for 1st PCR (Gradient PCR) 
 
For the purification of PCR product, absolute ethanol (analytical grade) was used 
to the post-PCR reaction mixture and was kept at -20° C for at least 1 hour. DNA was 
precipitated by centrifugation at 3,500 rpm (Eppendorf 5810 centrifuge, Germany) for 30 
minutes. The DNA was washed three times with 70% ethanol, with centrifugation 
between each wash at 3,500 rpm for 20 minutes. 
 
 
 
 
 
 
Figure 3.5 Centrifuge machine used for short spin as well as for purification 
of PCR product  
 
 
 
 
  
39 
 
 
3.4.3 Nested PCR 
 
The nested PCR was used to amplify the DNA fragment of interest for sequencing 
using 1st PCR product as DNA template. The ingredients of reaction mixture for nested 
PCR included:  
 
Forward primer                                      3.25 µl (each primer)  
Reverse primer                                      3.25 µl (each primer) 
Master mix 4 µl               x 50               200 µl 
Milliq        14.5µl _________________ 725 µl 
Taq pol     0.3 µl                                   15 µl 
DNA         0.6 µl                                     30 µl 
 
The reaction mixture was loaded in wells along with specific primers. DNA 
sample (0.6 µl in each well) was loaded in reaction mixture. PCR-plate was sealed, 
vortexed and spinned for 7 seconds in centrifuge machine.  PCR consisted of  
 Initial denaturation at 94 °C for 5 minutes,  
 30 cycles each of 30 seconds at 95 °C 
 30 seconds at 56°C, 1 minutes at 72 °C 
 Final extension step at 72 °C for 8 minutes (Applied Biosystem thermal 
cycler, model# 9902, Singapore). 
After the completion of reaction, PCR product was checked by Agarose gel 
electrophoresis (Cleaver Scientific limited, 100 volts) to confirm the presence of DNA 
fragment of interest for sequencing.  
Purification of 2nd PCR was done as described in section 3.4.2. 
3.5 Sequence reaction   
DNA fragment from nested PCR was dissolved in 20 µl of double distilled water 
by the use of program 5510 in thermocycler. Reaction mixture (15 µl) was prepared for 
sequencing; forward primer 0.72µl, sequencing buffer 3.00 µl (ABI UK 1203142), big 
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dye 0.75 µl (ABI UK 1201096), double distilled water 9.03 µl, and DNA 1.5 µl. The 
plates used for sequencing were 96-well plates (MicroAMP, Optical 96-well reaction 
plate, SG06812-4A, Applied Biosystem Singapore); the reaction mixture was loaded 
vortexed (Vortex, IKA MS-3 dgital) and short spun.  
A volume 13.5µl of reaction mixture was used in each well. Purified template of 
DNA (1.5 µl) from nested PCR was added to reaction mixture, in each well. Plates were 
sealed with the film and spinned for 7 seconds in centrifuge (3500 rpm). DNA 
sequencing reaction was performed with program BD3.1-F of PCR machine. After 
sequencing reaction, plates were taken out and spinned for 7 seconds in a centrifuge at 
3500 rpm to remove ethanol. 
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Figure 3.6 Sequencing plates and film used to seal the plates 
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3.6 Sequence reaction purification and DNA sequencing 
After sequence reaction 45 µl of 100% ethanol was added to each well and placed 
at 20 oC for 1 hour to precipitate the DNA. The plate of sequence reaction was taken out 
and allowed to thaw for one minute. The centrifugation of plate was done at 3,500 rpm 
for 30 minutes at room temperature to get the precipitates of DNA. Precipitates were 
washed three times with 75% ethanol and centrifuged at 3,500 rpm for 20 minutes. The 
plate was mapped with a piece of paper, spin down all solution for 7 seconds. Each air-
dried sequencing sample was dissolved in 10 µl Hi-deionized formamide (Hi-Di; Applied 
Biosystems Inc.). After adding Hi-Di the plate was sealed and denatured at 95 °C for 2-3 
minutes in 96-well thermo cycler, which was then taken out and quickly cooled in a 96-
well cooler (Figure 3.5 a and b). The DNA sequencing plate was placed in cooler for 3-5 
minutes, settled in the rack and adjusted in genetic analyzer (AB Hitachi (made in Japan) 
3130X/ Genetic Analyzer) to sequence the fragment of interest. 
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                               (a)                                                                           (b) 
Figure 3.7 DNA sequencing; Denaturation of DNA (a) Ice racks to kept cool the sequencing 
plates after denaturation (coolers) (b) rack to put the sequencing plate into genetic 
analyzer 
 
 
 
Figure 3.8     Genetic analyser ABI (Applied Biosystem) 
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Table 3.2 Primers designed and optimized for 1st and nested PCR along annealing temperature 
Gene SNPs No 1st PCR primers  PCRa 
 
Nested PCR primers 
 
PCRb  
 
Tempc. 
(◦C) 
Seqd. 
WFS1 
  
rs734312 f: ttccccatcgccagcaagga 
r: atcttcacgtgccgcctggt 
1,333 f: cgcctccatcggctacttcctct 
r: tcacgcggacgtacttgaagcg 
455 60 F 
POU2F1 rs3767434 
 
f: gtgggaggttgatgggagctgtc 
r: tcaaggtggcgaccacaccaa 
1,204 f:ggtaggtcatagagccaaggaggc 
r: tgggaggcccgttttgggtt 
798 62 R 
POU2F1 rs10918682  
rs2146727 
f: ccttggcctcccaaagtg 
r: gttctcagcacgcacttcc 
968 f: tgaggtttcatctcgtttgttg 
r: catttggtggtttcatcactg 
642 60 R 
KCNQ1 rs2237892 
 
f: acaggggcctacccacttacga 
r: cacctggtgtttggaccctgct 
1,760 f: atggcgtccttgtgcccttgtc 
r: tgtgccacctgccttccaagag 
685 62 F 
KCNQ1 rs2237895 
rs234864  
f: acaaaggcagcaccacagcgac 
r: aggacaccgtcttgagccagca 
1,560 f: tgctggggcaggggtgtctttag 
r: agattcaaggcgggtggcttgg 
579 56 R 
TCF7L2 rs290481 f: gcagcgctagcaagaggctt 
r: agacccattgctctgtcgcc 
1,839 f: gccctgcaccaaaaccagca 
r: tccctgccttcctgccatct 
520 60 F 
HHEX rs7923837 
 
f: cagctgggagctgcccttcctat 
r: gggatgttgaggggcttaccca 
1,798 f: tcttgcagtaagcctgacgggg 
r: cttggcctggctcttggccttct 
421 60 F 
ITGA2 rs1062535 
 
f: ggtgcttacctgtggagaggggt 
r:tcccagccttttctagtagagctgc 
1,063 f: acacatatgccctgacacacaagac 
r:ggcgtttctgtttaagtacccaagaac 
706 56 F 
NELL1 rs1459865 
 
f: ttgtcacagcacaccagttctcagc 
r: gcacctatacccagtcgttgccc 
1,080 f: tgtcatctgcttccttggttgaggt 
r: agagtggcccaggttcttgc 
781 60 F 
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NELL1 rs11026146 
 
f: ttctgcagatggatatttgagg 
r: agacagggccaatcaaaatg 
976 f: tgactagacccaatgctgtcc 
r: cgagggatccgttgaaataag 
743 60 F 
IDE rs6583813  
rs7910977 
f: gatttggcaaaacacacacg 
r: gcagaatctccttcccttcc 
997 f: acagggggaagggtatatgg 
r: gatcactcacccacctggtc 
737 60 F 
CDKL1 rs7756992 f: tgtgtcaccacacatggctag 
r: cagtcaactccaagacacatcc 
814 f: aggcatgagccactgtatcc 
r: aatgcaacaatggaaaagca 
528 56 R 
NPPA rs5063 
rs5064 
f: ccccgcttcttcattcggct 
r: tgtgaccttggtggctcggt 
1,428 f: acttgtgggggcacgacctcat 
r: ctgtgacaagccctgcgggatg 
568 60 R 
ADRB3 rs4994 
 
f: agtgcccagggagtgctatgct 
r: tgatgggcgcaaacgacacc 
831 f: actcctcccccaagagcggt 
r: cttggtgaccagtgcgccgt 
647 60 R 
PRKCB1 rs7404928 
 
f: tgctctgcacaatgcgaggt 
r: cacctcagagtactgtcagtcttaaat 
1678 f: tcaggacaccagagatggggtgaa 
r:aaatgaaatcagtgagaacatggggac 
585 56 R 
CETP rs1800775 
 
f: acaatagccgccgggaagtcct 
r: tgcgaggtgcctttggagca 
1,382 f: cacagttgctgcagggcagttc 
r: agccagacattcaacaagagcacc 
674 60 F 
GNB3 rs5443 
 
f: ttggtgctcttgcctgcgac 
r: ggcagggagcagtcatggcatt 
712 f: tgtgttggcagggctgcttctc 
r: gtcacccagtgacaagggacagc 
507 58 F 
LTA rs909253 
 
f: gagggtgctgtgggcaagat 
r:  ccccactccctggccctccc 
976 f: accccagcagcccccattct 
r: gcccgtgcttcgtgctttgg 
541 62 R 
LPL rs328 f: tctaggctgtctgcatgcctgtc 
r: tcccggagtatgctggcact 
833 f: agcttggttgctgaacaccaggt 
r: tgtggctgcaggtgatgcagt 
759 56 F 
IL1A rs1800587  
 
f: gtcacaggatggctcccaacgc 
r: accctgccctaaccaggagctt 
1,890 f: gctgctttcctcccagatccatgc 
r: aacagggccagggtggagagtt 
541 63.8 R 
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PCR a: 1st pcr product, PCRb: Nested PCR product, Tempc: Annealing temperature, Seqd: Sequencing primer, R: Reverse, F: Forward
IL1B rs1143634  
 
f: aaaggtagaaggcccagcgg 
r: acggctcaagcactcccagga 
852 f: acctgaagctggaacccatg 
r: acaggagtgtgaccctgagaa 
578 64 F 
PPARG rs1801282 
 
f: tcaaacccttcttcattctctcagct 
r: tgggagagctgaagtgcacac 
1,282 f: agtgccagccaattcaagcccag 
r: aggaaatgggagccatgcacagag 
512 56 R 
ADD1 rs4961 
 
f: ggctggcagcaagtaaaccctg 
r: accctagggctacagaactggc 
681 f: agcaccacgacatgggagca 
r: gcaaccctactcctcgt 
341 56 R 
PON1 rs854560 f: acagagttttggtgggccagagg 
r: agcagctgggaggcaaccaac 
1,833 f: atccctaggccagatggtgg 
r: agtctttgaggaaaaagctctagtcca 
888 53 R 
IL6 rs1800796 f: acagggagagggagcgat 
r: cagtacccccaggagaagat 
1,345 f: gccaacctcctctaagtg 
r: tcagacatctccagtcctat 
712 56 F 
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3.7  DNA Amplification 
Required DNA fragments were amplified through 1st and 2nd (nested) polymerase 
chain reaction (PCR) using genomic DNA in 1st amplification, following Wing-Sze Lo et 
al. (2007). 
3.7.1 1st PCR 
Amplification of DNA fragment was performed in a 20 μl PCR mixture, 
containing 50-60 ng of genomic DNA, 75 nmol/ L of each primer, 50 nmol/ L of each 
deoxyribonucleotide triphosphate (dNTPs: Promega USA U1515), 0.5 mM/ L 
magnesium chloride (MgCl2, Sigma: M2670), 1 U Taq DNA polymerase (Amersham 
Bioscience, Uppsala, Sweden) and genomic DNA 0.6 μl. The mixture was prepared for 
each plate in 2 Eppendorf tubes.  PCR conditions were same as described in section 3.4.1 
and there was a specific annealing temperature for each set of primers. 
3.7.1.1 1stPCR Material 
Forward primer                       0.5 µl                                   25 µl 
Reverse primer                         0.5 µl                                     25 µl 
Master mix                                     4 .0µl  x 50                   200 µl 
Milliq H2O 14.1 µl ________________ 705 µl 
Taq pol                                                 0.3 µl                                      15 µl 
DNA                                                          0.6 µl                                     30 µl 
  20 µl                                                                                                               1000 µl 
For the purification of PCR product, 60 µl of absolute ethanol (analytical grade) 
was used to the post-PCR reaction mixture and was kept at -20 °C for at least 1 hour. 
DNA precipitates were washed (Eppendorf 5810 centrifuge, Germany) three times with 
70% ethanol with centrifugation between washes at 3,500 rpm for 20 minutes. 
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3.7.2 Nested PCR 
DNA fragments were amplified by using nested PCR. DNA amplification was 
carried out in 20 μl reaction mixture consisting of 50-60 ng of genomic DNA, 2.5 mM 
magnesium chloride (MgCl2, Sigma: M2670), 200 M of each deoxyribonucleotide 
triphosphate (dNTPs: promega USA U1515), 125 nM of each primer and 1U Taq DNA 
polymerase (Amersham Bioscience, Uppsala, Sweden). PCR stages were as follow: 5 
minutes for denaturation at 95 °C, at 95 °C 30 cycles of 30 seconds, 30 seconds at 56 °C, 
2 minutes at 72 °C, and 72 °C for 8 minutes. All stages were same as in 1st PCR for 
nested PCR except 1 minute at 72 °C. Purification of PCR product was achieved by 
ethanol and stored at 4 °C for genotyping. 
1st PCR product was used as DNA template. PCR conditions were same as 
described in the section 4.3.3.  
3.7.2.1 Material for 50 reactions 
Forward primer                                    0.3 µl                          15 µl 
Reverse primer                                       0.3 µl                          15 µl 
Master Mix                                             4µl x 50                           200 µl 
Milliq H2O 14.5 µl _______________       725 µl 
Taq pol                                                         0.3 µl                                  15 µl 
DNA                                                               0.6 µl                 30 µl 
  20 µl                                                                                                                      1000 µl 
The PCR product was purified by using the absolute ethanol (analytical grade) 
and the mixture was kept at -20°C for at least 1 hour. After centrifugation at 3,500 rpm 
for 30 minutes at room temperature, it was washed with 75% ethanol three times.  
3.8 Agarose gel electrophoresis 
PCR product in each instance was resolved on 1.0% agarose gels with 1Kb DNA 
ladder (Fermentas) and stained with ethidium bromide (Sigma E7637) to confirm the 
presence of PCR product with the expected size and the absence of nonspecific products 
(Annexure II). 
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3.9 Sequence reaction  
Nested PCR product was dissolved in 20 µl of double distilled water and in 
sequence reaction. PCR product was pre-heated by using the program: 5510. Prepared the 
reaction mixture of 15 µl , forward primer 0.72µl, sequencing buffer 3.00 µl (ABI UK 
1203142), big dye 0.75 µl (ABI UK 1201096), double distilled water 9.03 µl, and DNA 
1.5 µl. Reaction mixture was vortexed  and spinned for 7 seconds Sequence reaction was 
performed by the program BD3.1-F in genetic analyzer. After sequence reaction 45µl of 
100% ethanol was added to each well and placed at -20 oC for 1 hour to precipitate the 
DNA. The sequencing material used included: 
Forward/reverse primer                      0.72 µl                                      36 µl 
Sequencing buffer                                      3.00 µl                                       150 µl 
Big dye                                                                       0.75µl  x 50                               37.5 µl 
DD water                       9.03 µl _____________ 451.5 µl 
DNA                                                                1.5 µl   
                                                                                  15 µl                                                                   750 µl 
3.9.1  Purification for sequence reaction and sequencing 
After centrifugation at 3,500 rpm for 30 minutes at room temperature, the 
precipitates were washed three times with 75% ethanol and centrifuged between washes 
(3,500 rpm for 20 minutes). Sequencing plate was sealed and spinned down all solution 
for 7 seconds. Each air-dried sequencing sample was dissolved in 10 µl Hi-deionized 
formamide (Applied Biosystems Inc.) and fragment of interest was sequenced using AB 
Hitachi (Japan) 3130X/ Genetic Analyzer. 
3.10 Data analysis 
Continuous values were presented as mean±SD and categorical values were 
presented in numbers as well as percentages. Association studies on the relationship 
between one continuous variable and other independent variables were carried out by 
'Kruskal Wallis', 'Mann Whitney U' test. Association of one categorical variable with 
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other independent variables were performed by chi-square test. The data was analysed by 
R version 2.11. A “p” value of less than 0.05 was considered as statistically significant.  
For association of genetic polymorphism with diabetes all control samples were 
considered maintaining Hardy-Weinberg Equilibrium. Fischer’s and Chi square (X2) P 
values were calculated for all the SNPs; and the SNPs with P < 0.05 were regarded as 
associated with diabetes. Frequencies of alleles and genotypes were calculated by SHEsis 
program and haplotype association was studied through haplotype (SHEsis program 
online: http://analysis2.bio-x.cn/myAnalysis.php). 
Haplotype association, linkage disequilibrium (LD = D') and correlation (r2) was 
studied through SHEsis program: http://analysis2.bio-x.cn/myAnalysis.php. Frequency 
less than 0.01 were ignored for the haplotype analysis. D'=1 known as complete LD and 
D' < 1 indicates the complete ancestral LD has been disrupted. Therefore, statistically 
significant values of D' that near to one (e.g. 0.9) provide a useful indication of minimal 
historical recombination. 
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CHAPTER 4 
RESULTS 
A total of 591 T2D patients (women = 358, men = 233) with age group in range 
of 20-80 years were included in this study. Average calculated age for diagnosis of 
diabetes in urban population was 49.65±10.84 years for women and for men was 
51.54±11.99 years where as mean age for studied rural population was 53.19±10.38 years 
for women and 57.15±11.63 years for men.  
4.1 Demographic Characteristics  
Mean calculated age for urban population was 49.65±10.84 years for women and 
for men was 51.54±11.99 years where as mean age for studied rural population was 
53.19±10.38 years for women and 57.15±11.63 years for men. Demographic 
characteristics of diabetes subjects are summarized in Table 1. Most of the (61.42%) 
patients were in range of 41-60 years of age in rural and urban population in both 
genders. Urban population was diagnosed with diabetes at the early age ≤ 35 years and 
rural population was with strong positive family history and diagnosed with diabetes at 
BMI lower than normal < 25. Hypertension was common with 62.27% among studied 
subject. One fourth of diabetes patients were using insulin for the treatment of disease. 
There was a low literacy rate among diabetes subjects with 47.7% and others were 
illiterate.  
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Figure 4.1 Average age of diabetes diagnosis in rural and urban population  
 
  
44
46
48
50
52
54
56
58
Rural Urban
Diabetes Population
Ag
e 
(Y
ea
rs
)
Female
Male
53 
 
 
Table 4. 1  Demographic distribution of T2D 
 Rurala (%) Urbanb (%) Total (%) 
No. 170 (28.77) 421 (71.23) 591 (100) 
Age 
20~40 
41~60 
≥ 61 
 
11 (6.47) 
109 (64.11) 
50 (29.41) 
 
90 (21.38) 
254 (60.33) 
77 (18.29) 
 
101 (17.09) 
363 (61.42) 
127 (21.4) 
Age at diagnosis 
≤ 35 
> 35 
 
12 (7.05) 
158 (92.93) 
 
129 (31.83) 
287 (68.16) 
 
146 (24.7) 
445 (75.3) 
BMIc 
≤ 25 
> 25 
 
109 (64.12) 
61 (35.88) 
 
117 (27.79) 
303 (71.99) 
 
226 (38.24) 
365 (61.75) 
Family history 
No 
yes 
 
4 (2.36) 
166 (97.6) 
 
134 (31.82) 
287 (68.16) 
 
138 (23.35) 
453 (76.65) 
Education 
Illiterate 
Primary 
college & above 
 
75 (44.11) 
63 (37.5) 
32 (18.82) 
 
175 (41.56) 
103 (24.46) 
143 (33.97) 
 
250 (42.3) 
166 (28.08) 
175 (29.61) 
Employment status 
Jobless 
Laborer 
Housewives 
Office job / business 
 
11 (6.48) 
36 (21.18) 
82 (48.23) 
41 (24.11) 
 
69 (16.4) 
72 (17.1) 
163 (38.72) 
117 (27.8) 
 
80 (13.54) 
108 (18.27) 
245(41.45) 
158 (26.73) 
Treatment 
Oral medication 
Insulin 
No medication 
Oral med. + insulin 
 
143 (85.63) 
23 (13.77) 
1 (0.60) 
3 (1.76) 
 
262 (62.23) 
127 (30.16) 
32 (7.6) 
0 
 
405(70.07) 
150(25.95) 
23(3.98) 
3(0.51) 
Results are presented in numbers of patients (percentage). Rurala; Rural population (Gujrat, Jhelum, 
Chakwal), Urbanb;  Urban population (Lahore, Rawalpindi/Islamabad), BMIc (Body Mass Index) was 
considered as being normal at ≤ 25 and known to be overweight at > 25 for both men and women according 
to WHO. 
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4.2  Distribution of BMI and family history in diabetes population 
It’s depicted from the Figure 4.1 that rural population was with BMI lower than 
normal. Both genders in urban population found as overweight even women were with 
higher BMI value than men. According to Figure 4.2, it’s revealed that majority of 
women in both studied populations were having positive family history which was more 
than men. 
It’s depicted from Figure 4.3 that more rural patients were with positive 1st degree 
relative family history as compare to urban diabetes population. Females in urban and 
rural areas were at higher risk of diabetes development than males and most of the rural 
men were diagnosed with positive family history. 
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Figure 4.2 BMI (Body Mass Index): Black (women) and grey (men) bars are representing the 
distribution of mean BMI in rural and urban diabetes population. BMI ≤ 25 is known 
to be normal according to WHO criteria and BMI > 25 was considered as overweight 
or obesity. 
 
Figure 4.3 Distribution of family history in rural and urban population: Black (rural) 
and grey (urban) %age (percentage). 
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4.3  Relationship of BMI and family history with the onset of diabetes 
Results (Figure 1) suggested that the overweight (BMI > 25) individuals were 
diagnosed with diabetes at early age ≤ 35 years (P = 0.01). It’s revealed from the Figure 
4.4 that the subjects with 1st degree relative positive family history, were diagnosed with 
diabetes at BMI < 25 and there was a significant relationship between diabetes 
development and overweight or obese (P = 0.0036) even in the absence of positive family 
history.  
4.4 Stress, depression, hypertension and exercise  
The differences in distribution of risk factors were not significant (P > 0.05) 
among both genders. A large number of patients were with hypertension in both males 
and females while a very few were doing exercise (Figure 4.5). 
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Figure 4.4 Relationship of BMI with age of diagnosis and family history of diabetes: P-Value 
for BMI and age of diagnosis was P= 0.01014, whereas for BMI vs. family history 
P= 0.0036 which was found to be significant (P < 0.05). the box plot representing the 
lower and upper limit of data, the median lines showed the average (mean). 
 
 
 
Figure 4.5 Risk factors distribution in T2D patients; P-value for exercise (Exe), stress (Str) and 
hypertension (Hyp) among men (black bars) and women (white bars) i.e. P > 0.05 
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4.5 Complications, care and management  
Distribution of retinopathy and nephropathy was 19.29% in diabetes population. 
Retinopathy and nephropathy were three times higher in rural population than urban. 
Cancer was a co-morbid disease with 1.66% in diabetic subjects in urban population.  
Over all 84.6% of patients cared about regularity in disease treatment and 33.84% 
checked their blood glucose level daily (Table 4.2) but there were patients who rarely 
care about their check of blood glucose level. The 42.81% of diabetic patients were not 
going for complete medical examination even for a single time in a year to avoid 
complications because they were not aware about the major complications (retinopathy, 
cardiovascular diseases and nephropathy) along diabetes due to low literacy rate.  
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Table 4.2 Clinical statistics of diabetes complications and management 
 
Rurala (%) Urbanb (%) Total (%) 
No.  of patients  170 421 591 
Duration of diabetes (years) 
0-5  
5-10  
>10  
 
131 (77.05) 
22 (12.94) 
17 (10) 
 
200 (47.5) 
91 (21.61) 
130 (30.9) 
 
331 (56) 
113 (19.12) 
147 (24.87) 
Complications 
Nephropathy 
Retinopathy 
Cancer 
Cardiovascular diseases 
Retinopathy & nephropathy 
 
0 
0 
0 
19 (11.18) 
64 (37.65) 
 
11 (2.61) 
43 (10.21) 
7 (1.66) 
48 (11.4) 
50 (11.88) 
 
11 (1.86) 
43 (7.27) 
7 (1.18) 
67 (11.34) 
114 (19.29) 
Treatment regularity 
Regular 
Irregular 
 
167 (98.24) 
3 (1.76) 
 
333 (79.1) 
88 (20.9) 
 
500 (84.6) 
91 (15.4) 
Blood glucose check frequency 
Daily 
Weekly 
Monthly 
Rarely 
 
125 (73.53) 
37 (21.76) 
6 (3.53) 
2 (1.18) 
 
75 (17.81) 
133 (31.6) 
113 (26.84) 
100 (23.8) 
 
200 (33.84) 
170 (28.76) 
119 (20.14) 
102 (17.26) 
Complete medical check/year 
No medical checkup/year 
Once/year 
Twice/year 
 
8 (4.71) 
145 (85.3) 
17 (10) 
 
245 (58.2) 
159 (37.8) 
17 (4.04) 
 
253 (42.81) 
304 (51.44) 
34 (5.75) 
 
Results are presented in numbers (percentages).  
Rurala and Urbanb: Referred to Table 1 
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4.6 Economic burden  
Mean estimated cost per patient per month was 1596.459 PKRs and mean annual 
cost of diabetes per patient was 19157.51 PKRs (210.92 US$). Middle income class was 
spending more in comparison to their income as compare to the lower and higher 
economic class with P value of 0.001 (Figure 2). There was a significant difference in 
distribution of disease cost among T2D patients which varied from 0-7000 PKRs per 
month. 
The correlation of cost with the education depicted (Table 3) that highly educated 
patients bearing more cost (P < 0.05) to manage the diabetes. Subjects with the higher 
income group were spending much more on disease care 1815.21±1205.86 per month (P= 
0.0017) as compare to other groups with low income. The population with > 10 years of 
disease duration had higher economic burden of the disease (P < 0.001) as compare to the 
patients with < 10 years. Patients getting treatment with insulin had more management 
cost (P < 0.001) then treatment with oral medication. Diabetic subjects with retinopathy 
were bearing higher treatment cost (2578.788±1059.20 PKRs) than nephropathy 
(1594.388±931.41) and CVD (2172.708±1026.34) as given in Table 3.   
Trend line predicted the diagnosis of diabetes at BMI lower than normal and at 
early age below 30 years. The determined cost of diabetes treatment was observed to be 
increasing in future due to higher medication cost.  
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Figure 4.6 Distribution of disease management cost according to monthly income: 
Distribution of cost in comparison to income (Pakistani rupees = PKRs) in T2D 
patients, P-value 0.001< 0.05. 
 
Figure 4.7 Frequency distribution of disease cost management among T2D patients: P-value 
0.001< 0.05. Cost: Depicted in PKRs. Frequency: Number of patients 
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Table 4.3 Correlation of cost of management with demographic chracteristics 
Demographic 
characteristics 
Women (cost/m) P-value Man  (cost/m) P-value All Subjects P-value 
(among groups) 
Age       
20~40 1464.73±847.22 0.2516 1761.83±740.05 0.0167 1542.65±821.45 0.9052 
41~60 1565.46±958.88  1685.34±960.02  1611.47±956.17  
>=61 1756.78±1044.92  1457.09±881.67  1596.65±965.51  
Education       
Illiterate 1508.25±982.95 0.05642 1419.82±780.47 0.1352 1503.90±936.38 0.02086 
Up to primary 1711.59±911.60  1581.62±843.55  1645.23±879.45  
Up to 
intermediate 
1649.67±968.81  1596.54±823.67  1622.98±882.85  
Graduate and 
above 
1506±837.68  2068.75±1312.15  1816.38±1145.25  
Employment 
status 
      
Jobless 1137.68±771.42 0.00303 1369.20±796.38 0.01106 1301.79±791.36 0.0009678 
Laborer 1381.60±798.60  1595.20±715.37  1504.01±1027.53  
House wife 1690.47±1032.14  NA  1687.48±1027.54  
Office job/ 
businessman 
1382.52±518.60  1779.13±1030.00  1668.46±934.77  
Income/month       
0-10000 1390.73±814.70 0.004838 1488.08±778.77 0.263 1429.57±798.35 0.001745 
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Table 4.3 continue 
10000-20000 1687.62±975.31  1634.60±797.85  1664.49±911.80  
20000-30000 1736.28±1158.97  1892.63±1256.58  1815.21±1205.86  
Duration        
1-5 years 1298.19±698.87 2.49E-007 1343.13±685.78 2.83E-008 1315.16±690.38 4.36E-015 
6-10 years 1662.89±1025.68  1907.89±921.32  1745.28±994.49  
>10years 2087.81±1130.57  2252.61±1104.64  2139.80±1110.21  
Treatment       
Through diet 
and exercise 
1095.24±121.99 2.20E-016 1212.963±384.40 3.50E-015 1161.458±297.32 2.20E-016 
Oral med. 1286.029±713.74  1273.391±623.43  1280.06±677.57  
Insulin 2526.515±918.60  2452.186±961.79  2489.514±929.52  
Oral med. + 
insulin 
1276.852±1103.41  2017.857±1102.72  1601.042±1147.65  
Complications       
Nephropathy  1529.432±898.13 1.60E-009 1730.848±974.63 0.0009876 1594.388±931.41 3.36E-01 
Retinopathy  2483.333±1212.14  2833.333±577.35  2578.788±1059. 20  
CVD 2372.593±1062.48  1925.758±956.13  2172.708±1026.34  
(Kruskal-W test: H0 cost is even) *All costs were measured in Pakistani currency and for international level, can be converted to US$ (Rs. 90.84 per 
US$). Data is presented as mean ± SD.   A p value less than 0.05 was considered as statistically significant. CVD: Cardiovascular diseases. Duration: 
duration of diabetes. Oral med: Oral medication. The above mentioned all costs (in Table 4.3) were of monthly expenditure 
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4.7 Genetics analysis 
4.7.1  Demographic characteristics of selected subjects 
It’s a case-control study and total of 458 samples were used for genetic analysis 
(280 patients, 170 controls). The selected subjects were in age group of 20-80 years. 
Twenty nine Single Nucleotide Polymorphisms were identified in candidate genes of 
Pakistani population. Demographic characteristics of the studied subjects were 
demonstrated (Table. 4.4). Minimum age at diagnosis of Type 2 Diabetes (T2D) was 20 
years for males and 22 years for females as well as positive family history (first degree 
relative) of T2D was more than 60% in both males and females (Table. 4.4). 
Cardiovascular diseases were reported as a major complication of diabetic patients. 
Hypertension was common among T2D subjects (males: 44.91%; females: 53.53%) and 
making the Pakistani population at risk. 
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Table 4.4 Demographic characteristics of Case-control subjects for genetic analysis 
Characteristics Case Control 
Male Female Male Female 
Number 118 170 104 66 
Age 51.79±0.989 y 49.48±0.837 y 36.61±2.041 y 38.34±2.314 y 
Age of 
diagnosis 
42.86±1.123 y 41.18±0.824 y - - 
Minimum age 
of diagnosis 
20 y 22 y - - 
BMI 26.38±0.478 26.95±0.629 25.60±0.563 26.34±0.903 
Family history 74 (62.71%) 110(64.70%) - - 
Nephropathy 
Retinopathy  
Cancer 
Cardiovascular 
diseases 
2 (1.12%) 
8 (4.49%) 
- 
23 (12.92%) 
7 (3.93%) 
19 (10.67%) 
3 () 
19 (10.67%) 
- 
- 
- 
- 
- 
- 
- 
- 
Hypertension 53(44.91%) 91 (53.53%) - - 
Data is presented in numbers, %age and mean±SD 
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4.8  Nested PCR Products for DNA Sequencing 
PCR and sequencing primers were optimized for SNPs identification (Table 3.1) 
and gel electrophoresis was used to confirm the presence of final PCR product before 
DNA sequencing (Figures 4.8, 4.9 and 4.10).  
4.9 Identification of SNPs sites in DNA Sequence 
The chromatographs represent the homozygous and heterozygous SNP sites in 
targeted DNA sequences of candidate genes. The identified SNP in chromatograph was 
denoted by the symbol ( ). The SNP Pro Ala (rs1801282) was only with one 
homozygous (GG) and a heterozygous (GC) genotype. 
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Figure 4.8 rs328 (LPL gene); PCR product size: 759 bp (base pairs); column 1: 
DNA ladder; Column 2-16: PCR products of different DNA samples 
 
 
 
 
Figure 4.9  rs7923837 (HHEX gene); PCR Product size: 421 bp (base pairs); 
Column 1: DNA Ladder: Column 2-17: PCR product of different DNA 
samples 
 
 
 
Figure 4.10 rs10918682 and rs2146727 (POU2F1); PCR Product size: 642 bp (base 
pairs); Column: 2-13 and 15-16 showed PCR product of DNA from 
various subjects  
 1      2      3       4      5     6        7     8      9      10   11    12    13     14   15    16 
1      2       3       4      5      6       7       8      9     10     11    12    13    14   15     16     17 
  1       2      3       4       5       6       7       8       9      10    11     12     13   14    15    16     17 
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(a) 
 
(b) 
Figure 4.11 Chromatograph representing the genetic polymorphism 
in rs1801282; (a) GC, (b) GG  
 
 
(a) 
 
(b) 
 
(c) 
Figure 4.12 Chromatograph representing the Polymorphism in 
rs1800775; (a) AC, (b) AA, (c) CC  
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(a) 
 
(b) 
 
 (c) 
Figure 4.13 Chromatograph representing the genetic 
polymorphism in PON1 gene; rs854560, (a) AT, (b) AA, (c) TT 
 
(a) 
 
(b) 
 
(c) 
Figure 4.14 Chromatograph representing the genetic 
polymorphism in ITGA2 gene; (a) AG, (b) GG, (c) AA 
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(a) 
 
(b) 
 
(c) 
Figure 4.15 Chromatograph representing the genetic 
polymorphism in interlukin-1a; rs1800587, (a) AG, (b) GG, (c) 
AA  
 
 
 
(a) 
 
(b) 
 
(c) 
Figure 4.16 Chromatograph representing the genetic 
polymorphism in WFS1; rs734312, (a) AG, (b) AA, (c) GG  
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4.10 Association of diabetes with genetic polymorphism 
Over all twenty nine SNPs from 22 genes were analyzed for their genetic 
association with diabetes. Hardy Weinberg Equilibrium (HWE) was estimated for the 
control samples selected in the study. Out of twenty nine SNPs eighteen were in HWE 
while eleven were deviating (rs3767434, rs2237895, rs234864, rs290481, rs79238837, 
rs1459865, rs11026146, rs7756992, rs5063, rs7404928, rs909253 and rs4961) (Table 
4.6).  A total of eleven SNPs were found to be associated with diabetes in population of 
central Punjab Pakistan. The P-values for the association were derived from Fischer’s as 
well as chi square test (P < 0.05) and the association of genetic polymorphism with type 
2 diabetes was summarized in Table 4.5. Allele and genotype frequencies were given in 
Table 4.6 for diabetes association.   
Five SNPs were studied from 11th chromosome, KCNQ1 gene was sequenced for 
3 SNPs and out of them only rs234864 (P – 0.014) showed association with T2D [OR: 
0.607 (0.413-0.893)]. The rs2237895 and rs2237892 did not confer any risk for the 
development of diabetes (P > 0.05). Both SNPs rs11026146 and 1459865 from NELL1 
gene did not showed any significant association with diabetes.  
Chromosome 10 was playing role in the development of diabetes and four SNPs 
were identified in TCF7L2 and HHEX/IDE. The rs290481 from TCF7L2 did not depict 
any association while rs7923837 and rs7910977 from HHEX/IDE had a linkage with the 
onset of type 2 diabetes. In rs7923837 risk allele “AG” with frequency of 0.402 was 
higher in patients than in control subjects (0.189) with OR [0.658 (0.491-0.881)] and its 
P-value was 0.006.  The rs7910977 (P - 0.016) was significantly associated with T2D 
and C was the major allele with OR [1.647 (1.112, 2.438)] in Pakistani population. The 
rs6583813 from IDE was not associated with the development of T2D in studied 
population (P – 0.136). 
The genes POU2F1 and NPPA are located on 1st chromosome and five SNPs 
were targeted on this locus, out of them rs10918682 from POU2F1 and rs5063 from 
NPPA depicted the significant linkage (P – 0.000 and P – 0.015 respectively) with 
diabetes development. Heterozygous “AG” of rs10918682 was a risk genotype associated 
with onset of diabetes in Pakistani population.     
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Pro Ala (rs1801282) from PPARG (P – 0.007) was only with two genotypes (CC 
and CG) and G was a major allele where as “CG” genotype frequency was greater 
(0.203) in patients than control (0.080). The genetic polymorphism in ITGA2 
(rs11026146), LTA (rs909253), ADD1 (rs4961), PON1 (rs854560) and IL6 (rs1800796) 
were significantly associated with development of diabetes at single site analysis and 
genotype level as given in Table 4.5 and 4.6 (P < 0.05). The rs734312 from WFSI and 
rs5443 from GNB3 were associated with T2D at genotype level (P < 0.05) but did not 
depicted association with diabtese by single site analysis (P > 0.05). The rs2237892 from 
KCNQ1showed marginal association with T2D at genotype analysis (P - 0.05). 
The studied SNPs were strongly associated with T2D onset while few genes have 
not any impact or risk for diabetes such as ADRB3 (4994), PRKCB1 (rs7404928) and 
CETP (rs1800775) in Punjabi population of Pakistan. 
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Table 4.5 Association tests of genetic variants with T2D 
Gene rs No. HWE 
P-value 
Allele 1 
(D/C) 
Allele 2 
(D/C) RR (95% CI) 
OR (95% CI): P-value 
(X2) 
WFS1 S1_rs734312 >  0.05 A(313/182) G(261/122) 0.911 (0.809, 1.025) 0.804 (0.606, 1.066) 0.1481 
POU2F1 
 
S2_rs3767434 
S3_rs10918682 
S4_rs2146727 
< 0.05 
>  0.05 
> 0.05 
A(245/226) 
G(99/44) 
G(144/87) 
T(41/20) 
A(313/210) 
A(256/165) 
1.763 (1.062, 2.927) 
2.980 (1.892, 4.691) 
1.551 (0.951, 2.528) 
1.891 (1.076, 3.325) 
3.606 (2.165, 6.004) 
1.643 (0.949, 2.846) 
0.090 
0.0001* 
0.764 
KCNQ1 S5_rs2237892 
S6_rs2237895 
S7_rs234864 
> 0.05 
< 0.05 
< 0.05 
C(415/296) 
C(166/181) 
G(154/73) 
T(5/0) 
A(210/67) 
A(224/75) 
0.988 (0.978, 0.999) 
0.831 (0.687, 1.006) 
0.767 (0.063, 0.933) 
0.000  
0.689 (0.457, 1.025) 
0.607 (0.413, 0.893) 
0.153 
0.082 
0.014* 
TCF7L2 S8_rs290481 < 0.05 G(240/190) A(93/60) 0.918 (0.788, 1.070) 0.815 (0.559, 1.187) 0.331 
HHEX S9_rs7923837 < 0.05 A(236/153) G(293/125) 0.811 (0.703, 0.935) 0.658 (0.491, 0.881) 0.006* 
ITGA2 S10_rs1062535 > 0.05 A(157/139) G(209/133) 0.839 (0.711, 0.991) 0.719 (0.524, 0.985) 0.048* 
NELL 1 S11_rs1459865 < 0.05 G(208/140) A(206/112) 0.923(0.820, 1.039) 0.808(0.590, 1.106) 0.211 
NELL 1 S12_rs11026146 < 0.05 A(194/149) C(196/121) 0.915(0.806, 1.038) 0.804 (0.589, 1.097) 0.194 
IDE S13_rs6583813 
S14_rs7910977  
> 0.05 
> 0.05 
C(228/154) 
C(312/178) 
T(166/86) 
T(66/62) 
0.902 (0.795, 1.024) 
1.113 (1.019, 1.215) 
0.767 (0.551, 1.068) 
1.647 (1.112, 2.438) 
0.1367 
0.0163* 
CDKL1 S15_rs7756992 < 0.05 G(122/86) A(306/200) 0.948 (0.752, 1.195) 0.927 (0.668, 1.288) 0.7136 
NPPA S16_rs5063 
S17_rs5064 
< 0.05 
> 0.05 
G(332/222) 
C(340/181) 
A(32/26) 
T(48/19) 
1.082 (1.014, 1.155) 
1.302 (0.787, 2.154) 
1.932 (1.158, 3.222) 
1.345 (0.767, 2.357) 
0.015* 
0.3676 
ADRB3 S18_rs4994 > 0.05 C(37/27) T(283/185) 1.013 (0.950, 1.081) 1.116 (0.657, 1.896) 0.7862 
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Table 4.5 continue 
 
PRKCB1 S19_rs7404928 < 0.05 C(183/138) T(183/142) 0.986 (0.845, 1.150) 0.972 (0.712, 1.327 ) 0.9199 
CETP S20_rs1800775 > 0.05 A(230/161) C(136/103) 1.030 (0.910, 1.167) 1.082 (0.781, 1.499) 0.696 
GNB3 S21_rs5443 > 0.05 C(268/161) T(150/73) 0.932 (0.833, 1.042) 0.810(0.576, 1.140) 0.2608 
LTA S22_rs909253 < 0.05 C(13/32) T(352/304) 1.066 (1.024, 1.109) 2.842 (1.465, 5.514) 0.002* 
LPL S23_rs328 > 0.05 C(481/240) G(57/32) 1.013 (0.962, 1.068) 1.125 (0.710, 1.782) 0.7011 
IL1A S24_rs1800587  > 0.05 C(220/195) T(132/141) 0.892 (0.743, 1.075) 0.830 (0.611, 1.127) 0.263 
IL1B S25_rs1143634 > 0.05 C(498/292) T(70/44) 1.009 (0.958, 1.062) 1.072 (0.716, 1.605) 0.815 
PPARG S26_rs1801282 > 0.05 C(61/17) G(497/303) 2.058 (1.224, 3.460) 2.188 (1.254, 3.815) 0.0071* 
ADD1 S27_rs4961 < 0.05 C(183/55) A(307/217) 1.847 (1.421, 2.401) 2.352 (1.661, 3.331) 0.0001* 
PON1 S28_rs854560 > 0.05 T(73/59) A(465/249) 0.708 (0.518, 0.969) 0.663 (0.455, 0.965) 0.0398* 
IL6 S29_rs1800796 > 0.05 C(267/110) G(259/42) 0.701 (0.616, 0.798) 0.394 (0.265, 0.584) 0.0001* 
HWE (Hardy-Weinberg Equilibrium): P < 0.05 (Significant), P > 0.05 (Non-significant); * represent the significant association of diabetes associated-
SNPs P > 0.05, OR: Odd Ratio, RR: Relative Risk, X2: Chi Square, D/C: Disease/Control 
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Table 4.6 Distribution of allelic and genotypic frequencies in cases and controls 
SNP_ID Case/control Case/control P value 
M m MM Mm mm 
S1_rs734312  A (0.528/0.560) G (0.461/0.349) AA(0.253/0.383) AG(0.552/0.354) GG (0.185 / 0.171) 0.0001* 
S2_rs3767434 A (0.857/0.908) G (0.143/0.092) AA(0.734/0.849) AG(0.245/0.118) GG (0.021 / 0.034) 0.07 
S3_rs10918682 A (0.76 / 0.919) G (0.240/0.081) AA (0.597/ 0.855) AG(0.325/0.129) GG (0.078 / 0.016) 0.0001* 
S4_rs2146727 A(0.640/0.655) T(0.360 / 0.345) AA (0.430 /0.460) AG(0.420/0.389) GG (0.150 / 0.151) 0.84 
S5_rs2237892 C (0.988/1.00) T (0.012/0.00) CC (0.976/1.00) CT (0.024/0.00) TT (0.00/0.00) 0.05* 
S6_rs2237895 G (0.446/0.527) T (0.554/0.473) GG (0.270/0.452) GT (0.351/0.151) TT (0.378/0.397) 0.002* 
S7_rs234864 T (0.593/0.500) C (0.407/0.593) TT (0.407/0.425) CT (0.370/0.151) CC (0.222/0.425) 0.0003* 
S8_rs290481 G (0.719/0.760) A (0.281/0.240) GG (0.557/0.656) AG(0.323/0.208) AA (0.120/0.136) 0.09 
S9_rs7923837 A (0.475/0.578) G (0.525/0.422) AA (0.265/0.457) AG(0.418/0.240) GG (0.316/0.302) 0.0001* 
S10_rs1062535 A (0.423/0.518) G (0.577/0.482) AA (0.171/0.275) AG (0.503/0.486) GG (0.326/0.239) 0.49* 
S11_rs1459865 G (0.500/0.556) A (0.498/0.444) GG (0.309/0.397) AG (0.386/0.317)  AA (0.304/0.286) 0.24 
S12_rs11026146 C (0.505/0.448) A (0.492/0.552) AA (0.333/0.407) AC (0.318/0.289) CC (0.344/0.304) 0.47 
S13_rs6583813 C (0.579/0.639) T (0.421 /0.361) CC (0.369 / 0.418) CT(0.421 /0.443) TT (0.210 /0.139) 0.27 
S14_rs7910977 C(0.823 /0.748) T(0.177 /0.252) CC (0.712 / 0.592) CT (0.223/0.312) TT (0.065 / 0.096) 0.08 
S15_rs7756992  A (0.713/0.699)  G (0.287/0.301) AA (0.589/0.580) AG(0.248/0.238) GG(0.184/0.182) 0.899 
S16_rs5063  C (0.910/0.850) T (0.090/0.150) CC (0.844/0.761) CT(0.133/0.177)  TT(0.023/0.062) 0.126 
S17_rs5064  G (0.874/0.905) A (0.126/0.095) GG(0.773/0.820) AG(0.201/0.170) AA(0.026/0.010) 0.516 
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Table 4.6 continue 
 
S18_rs4994 A (0.884/0.874) G (0.116/0.126) AA (0.792/0.785) AG(0.182/0.178) GG (0.025/0.037) 0.847 
S19_rs7404928 A (0.500/0.507) G (0.500/0.493) AA (0.317/0.400) AG (0.366/0.214) GG (0.317/0.386) 0.01* 
S20_rs1800775 A (0.630/0.608) C (0.370/0.392) AA (0.337/0.358) AC (0.586/0.500) CC (0.077/0.142) 0.124 
S21_rs5443  C (0.641/0.688) T (0.359/0.312) CC (0.474/0.462) CT (0.335/0.453) TT (0.191/0.085) 0.016* 
S22_909253 A (0.964/0.905) G (0.036/0.095) AA (0.951/0.845) AG (0.027/0.119) GG (0.022/0.036) 0.002* 
S23_rs328 C (0.894/0.884) G (0.106/0.116) CC (0.792/0.768) CG (0.204/0.232) GG (0.004/0.00) 0.63 
S24_rs1800587  C (0.615/0.577) T (0.385/0.423) CC (0.314/0.320) CT (0.603/0.514) TT (0.083/0.166) 0.06 
S25_rs1143634 C (0.865/0.860) T (0.117/0.134) CC (0.747/0.726) CT (0.235/0.269) TT (0.00/0.00) 0.41 
S26_rs1801282 G (0.890/0.947) C (0.108/0.053) GG (0.787/0.906) CG (0.206/0.081) CC (0.004/0.013) 0.004* 
S27_rs4961 G (0.634/0.769) T (0.366/0.231) GG (0.537/0.674) GT (0.194/0.189) TT(0.269/0.136) 0.008* 
S28_rs854560 T (0.806/0.734) A (0.126/0.174) TT (0.690/0.571) AT(0.231/0.326) AA (0.011/0.011) 0.05* 
S29_rs1800796 C (0.490/0.719) G (0.508/0.275) CC (0.342/0.579) CG (0.293/0.289) GG(0.361/0.132) 0.001* 
* = P < 0.05 represents the significant association of SNPs; M = Major allele; m = Minor allele 
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4.11  Haplotype analysis 
Haplotype analysis was performed for the SNPs which were significantly 
associated with diabetes on the chromosome 1 at locus of POU2F1 gene (Table 4.7). 
Haplotype G-G-A from POU2F1 (rs2146727-rs10918682-rs3767434) was associated 
with the susceptibility of T2D [P < 0.001, OR = 4.451(1.951-10.196)] while G-A-A was 
protective against the risk of diabetes onset [P < 0.001, OR = 0.332 (0.186-0.592)]. 
The haplotypes between POU2F1 and NPPA (Table 4.8) were not susceptible to 
diabetes except T-C-T-C-G which was a protective haplotype for disease onset (P = 
0.034). Haplotype analysis (Table 4.9) of rs1800587 (IL1-alpha) and rs1143634 (IL1-
beta) located on chromosome 2 determined that haplotype of major alleles C-C was 
associated with the increase of diabetes susceptibility [P < 0.05, OR = 1.488 (1.099-
2.014)]. Moreover the C-T haplotype was higher in frequency in controls as compare to 
patients [P < 0.01, OR = 0.298 (0.139-0.639) indicating protection against diabetes.  
A highly susceptible locus was identified at chromosome 4 containing three 
haplotypes (Table 4.10) at rs734312-rs4961 increasing the diabetes risk (P < 0.01). The 
haplotypes of rs854560 from PON1 and rs1800796 from IL6 (Chromosome 7) were 
significantly associated (Table 4.11) with the onset of diabetes and A-C, T-C and T-G 
showed the significant association (P < 0.05). Among haplotypes of rs4994-rs328 on 
chromosome 8 only G-G was increasing the risk of T2D in Punjabi population of 
Pakistan (Table 4.12). Chromosome 11 with 5 SNPs from KCNQ1 and NELL1 genes 
showed three susceptible and one protective haplotype against T2D in Pakistani 
population (Table 4.13). Haplotypes from IDE gene (rs6583813 & rs7910977) depicted 
C-T with 0.252 frequency in controls than 0.173 in patients conferring as protective 
haplotype against diabetes [P = 0.02, OR = 0.635 (0.419-0.931)]. Only one protective and 
one risk haplotype was identified on chromosome 10 with 4 SNPs (Table 4.14). 
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Table 4.7 Haplotype analysis for POU2F1 gene located on chromosome 1 
Bold P values indicating the significant haplotypes associated with diabetes distribution 
 
 
Table 4.8 Loci chosen for haplotype analysis on chromosome 1 (POU2F1-NPPA) 
The selected SNP from the loci for haplotype; rs2146727-rs10918682-rs3767434-rs5063-rs5064 (POU2F1-
NPPA gene): Bold P values indicating the significant haplotypes associated with diabetes distribution 
  
Haplotype Case (freq) Control 
(freq) 
P value OR (95% CI) 
A-A-A 0.567 0.561 0.916 1.024 (0.662-1.583) 
A-A-G 0.077 0.067 0.732 1.158 (0.499-2.685) 
G-A-A* 0.109 0.269 0.001 0.332 (0.186-0.592) 
G-G-A* 0.199 0.053 0.001 4.451 (1.951-10.156) 
Haplotype Case (freq) Control (freq) P value OR (95% CI) 
C-C-C-C-G 0.031 0.023 0.702946 1.353 [0.285~6.425] 
C-C-T-C-G 0.116 0.049 0.058280 2.564 [0.940~6.995] 
T-C-T-C-G* 0.103 0.199 0.034768 0.472 [0.232~0.957] 
T-T-C-C-G 0.062 0.059 0.901 1.068 [0.379~3.013] 
T-T-T-C-A 0.061 0.053 0.75 1.191 [0.406~3.489] 
T-T-T-C-G 0.458 0.434 0.639 1.127 [0.683~1.861] 
 
T-T-T-T-G 0.048 0.082 0.278 0.573 [0.207~1.585] 
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Table 4.9 Selected SNPs (rs1800587, rs1143634) located on chromosome 2 
 
 
 
 
 
 
 
 
The bold P values depicted a significant association with disease onset or protection against diabetes 
development 
 
Table 4.10 Haplotype analysis of SNPs located on chromosome 4 (WFS1-ADD1) 
Bold P values and haplotypes with * indicating significant association. Selected SNPs for analysis were 
rs734312-rs4961 
Table 4.11: Haplotype analysis for rs854560, rs1800796 (Chromosome-7) 
Haplotype- Case-(freq) Control-(freq) P value Odds-Ratio 
A-C* 0.068 0.173 0.0001 0.348-[0.203~0.598] 
A-G 0.072 0.056 0.474 1.316[0.619~2.797] 
T-C* 0.420 0.562 0.002 0.564-[0.394~0.808] 
T-G* 0.440 0.210 0.001 2.965-[1.951~4.505] 
Bold P values and haplotypes with * indicating significance  
Haplotype Case-(freq) Control-(freq) P-value OR-(95%-CI) 
C-C* 0.595 0.497 0.01 1.488-(1.099-2.014) 
C-T* 0.026 0.084 0.001 0.298-(0.139-0.639) 
T-C 0.307 0.372 0.071 0.746-(0.543-1.026) 
T-T 0.072 0.047 0.178 1.556-(0.184-2.975) 
Haplotype Case-(freq) Control-(freq) P-value OR-(95%-CI) 
A-G* 0.338 0.437 0.001 0.57 (0.419-0.777) 
A-T* 0.205 0.125 0.007 1.807 (1.174-2.781) 
G-G 0.288 0.316 0.46 0.873 (0.682-1.213) 
G-T* 0.169 0.086 0.002 2.160 (1.313-3.551) 
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Table 4.12 Haplotype analysis of loci chromosome 8 (ADRB3-LPL) 
Bold P values and haplotypes with * indicating significance. Selected SNPs for analysis were rs4994-rs328 
 
 
Table 4.13 Haplotype analysis of KCNQ1-NELL1 located on chromosome 11 
The selected SNPs for haplotype in the above table were rs2237892-rs2237895-234864-1459865-
11026146. The bold P values representing the significant association of haplotype with T2D 
  
Haplotype Case-(freq) Control-(freq) P-value OR-(95%-CI) 
A-C 0.771 0.790 0.62 0.839-(0.572-1.359) 
A-G 0.117 0.086 0.285 1.404-(0.752-2.621) 
G-C 0.096 0.07 0.315 1.418-(0.716-2.811) 
G-G* 0.016 0.054 0.02 0.286-(0.094-0.869) 
Haplotype Case (freq) Control (freq) P-value OR (95%-CI) 
C-G-C-A-A 0.084 0.047 0.226 1.862 (0.672-5.162) 
C-G-C-A-C 0.127 0.188 0.147 0.619 (0.322-1.188) 
C-G-C-G-A* 0.098 0.227 0.002 0.366 (0.187-0.716) 
C-G-C-G-C 0.095 0.038 0.068 2.654 (0.899-7.836) 
C-G-T-G-A 0.006 0.038 0.513 0.153 (0.108-1.328) 
C-T-T-A-A* 0.138 0.009 0.0001 17.298(2.43-122.64) 
C-T-T-A-C 0.15 0.122 0.506 1.268 (0.629- 2555) 
C-T-T-G-A* 0.130 0.256 0.006 0.427 (0.231-0.790) 
C-T-T-G-C* 0.129 0.027 0.003 5.349 (1.588-18.014) 
81 
 
 
 
 
Table 4.14 Haplotype analysis of 4 SNPs chromosome 10 (IDE/HHEX, TCF7L2) 
The bold P values representing the significant association of haplotype with T2D 
 
 
 
Table 4.15 Haplotype analysis for Chromosome 16 (PRKCB1-CETP) 
Haplotype- Case-(freq) Control-(freq) Fisher's-P Odds-Ratio 
A-A 0.323 0.314 0.888 1.028-(0.701-1.506) 
A-C 0.177 0.204 0.425 0.832-(0.529-1.308) 
G-A 0.302 0.298 0.981 1.005-(0.681-1.482) 
G-C 0.198 0.175 0.545 1.152-(0.729-1.821) 
(rs7404928-rs1800775) 
 
  
Haplotype Case (freq) Control (freq) Fisher's-P Odds-Ratio 
A-A-C-C 0.032 0.013 0.126 2.482 (0.561-10.98) 
A-A-C-T* 0.027 0.069 0.046 0.374 (0.138-1.017) 
A-A-T-C 0.074 0.058 0.522 1.299 (0.582-2.901) 
A-G-C-C 0.105 0.067 0.175 1.648 (0.795-3.413) 
A-G-T-C 0.04 0.05 0.796 0.88 (0.333-2.325) 
G-A-C-C 0.152 0.118 0.311 1.352 (0.753-2.425) 
G-A-C-T* 0.054 0.112 0.035 0.456 (0.216-0.960) 
G-A-T-C 0.174 0.214 0.324 0.778-(0.473-1.282) 
G-G-C-C 0.144 0.15 0.875 0.956-(0.548-1.667) 
G-G-C-T 0.076 0.071 0.79 0.905-(0.437-1.876) 
G-G-T-C 0.107 0.07 0.191 1.608-(0.784-3.295) 
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4.12 Linkage disequilibrium test 
Linkage Disequilibrium (LD) of genetic variants revealed the possible genetic 
recombinations (D') between the SNPs with in a loci. Recombination in two genetic 
variants (rs7910977, rs6583813) of IDE gene was 96% (D' = 0.968) and correlation 
coefficient (r2 = 0.160) indicated the two SNPs are not good predictor of each other. 
Strong LD was described in POU2F1 gene (rs3767434, rs10918682, rs2146727) with 
93% (D' = 0.937) recombination. Correlation between rs10918682 and rs2146727 
revealed that these two SNPs are good predictor of each other (r2 = 0.419) and have more 
chances to transfer to next generation.  No correlation was detected in IL1α (rs1143634) 
and IL1β (rs1800587). LD in 5 SNPs at chromosome 1 (Figure 4.11) predicted genetic 
recombination in 10918682-rs2146727 and rs3767434-rs5063 but they were not in a high 
positive correlation with each other. At chromosome 11 in gene KCNQ1 the three SNPs 
were in strong linkage (red color) as were present in the same gene. Moreover rs2237895 
and rs234864 were strong predictor of their transmission together in the next generation 
(Figure 4.12). 
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(a) 
 
 
(b) 
Figure 4.17 Location and map of Linkage Disequilibrium (LD) in SNPs at chromosome 1 
are presented. The SNPs numbers are indicated at the top of haploview. The 
pairwise LD Coefficient (r2) presented at top and LD = D/ at bottom 
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(a) 
 
 
(b) 
Figure 4.18 Location and map of Linkage Disequilibrium (LD) in SNPs at chromosome 
11 are presented. The SNPs numbers are indicated at the top of haploview. 
The pairwise LD Coefficient (r2) presented at top and LD = D/ at bottom 
  
85 
 
 
 
 
(a) 
 
(b) 
 
Figure 4.19  Location and map of Linkage Disequilibrium (LD) in SNPs at 
chromosome 10 are presented. The SNPs numbers are indicated at the top 
of haploview. The pairwise LD Coefficient (r2) presented at top and LD = 
D/ at bottom 
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4.13 Association of SNPs with Demographic Characteristics 
Table 4.16 and 4.17 represents the association of demographic and pathological 
features with genotypes of rs1800796 from IL6 and rs7756992 from CDKL1. No 
association was found between diabetes demographics and NPPA, PPARG, GNB3 in 
patients. The genotype CC of rs1800796 (IL6) was associated with family history of 
diabetes (P = 0.008) and was also gender specific in patients (P = 0.002). Genotype CC 
of rs1800796 was increasing the risk of diabetes development in comparison to CG and 
GG genotypes (Table. 5). The rs7756992 in Table 6, CT genotype was associated with 
gender specificity as well as it also increasing the risk of complications in diabetes 
patients (P < 0.05). The genotypes CC and TT did not show any association with the 
diabetes demographics. 
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Table 4.16 Association of demographic and pathological features between alleles of 
rs1800796 
Demographics  CC genotype CG genotype GG genotypes 
OR (95% 
CI) 
P value OR(95% CI) P 
value 
OR(95% 
CI) 
P 
value 
Gender  3.775 
(1.630 
8.652) 
0.002*  0.776 (0.288 
2.094) 
0.617 0.894 (0.396 
2.020) 
0.788 
BMI 0.867 
(0.515 
1.459) 
0.590 1.122 (0.419 
3.009) 
0.818 1.419 (0.669 
3.007) 
0.362 
Age 1.034 
(0.965 
1.107) 
0.343 0.946 (0.861 
1.039) 
0.245 1.058 (0.989 
1.132) 
0.103 
Age of 
diagnosis 
0.961 
(0.895 
1.033) 
0.280 1.059 (0.962 
1.164) 
0.242 0.972 (0.907 
1.042) 
0.427 
Family History 0.414 
(0.216 
0.795) 
0.008* 0.582 (0.246 
1.373) 
0.216 1.102 (0.768 
1.581) 
0.599 
Hypertension 1.036 
(0.749 
1.432) 
0.833 1.097 (0.709 
1.697) 
0.678 1.000 (0.682 
1.465) 
0.999 
Complications   1.017 
(0.931 
1.111) 
0.704 1.001 (0.892 
1.123) 
0.984 1.038 (0.940 
1.145) 
0.462 
Duration of 
diabetes 
0.790 
(0.451 
1.384) 
0.411 1.163 (0.596 
2.267) 
0.658 0.960 (0.526 
1.754) 
0.896 
* = P < 0.05 represents the significant association of genotype with demographic characteristics 
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Table 4.17 Association of demographic and pathological features between alleles of 
rs7756992 
Demographics CC  genotype CT  genotype TT  genotypes 
OR  (95%  
CI) 
P  
value 
OR  (95%  
CI) 
P  
value 
OR  (95%  
CI) 
P  
value 
Gender   1.173  
(0.371 -
3.705) 
0.786 0.313  
(0.120-  
0.820) 
0.018* 0.679  
(0.291-  
1.584) 
0.370 
BMI 0.955  
(0.477-  
1.911) 
0.897 0.782  
(0.518-  
1.181) 
0.243 1.101  
(0.613-  
1.977) 
0.747 
Age 0.986  
(0.898-  
1.081) 
0.757 0.969  
(0.839-  
1.051) 
0.448 0.983  
(0.918-  
1.053) 
0.630 
Age  of  
diagnosis 
1.034  
(0.938  
1.139) 
0.502 1.055  
(0.970  
1.149) 
0.212 1.042  
(0.969  
1.120) 
0.266 
Family  History 1.284  
(0.605-  
2.782) 
0.515 1.359  
(0.700-  
2.637) 
0.365 1.257  
(0.675-  
2.343) 
0.471 
Hypertension 0.906  
(0.564-  
1.456) 
0.684 0.840  
(0.549-  
1.283) 
0.419 0.827  
(0.580-  
1.179) 
0.294 
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CHAPTER 5 
DISCUSSION 
Pakistan is a developing country with 10% of Type 2 Diabetes (T2D) population 
and is ranked at 6th number in diabetic ranking countries throughout the world (Shera et 
al., 1995b). Punjab is the most developed province comprising 65% of the total Pakistani 
population. Urbanization and developments has changed the life style from active to 
sedentary due to TV watching, office jobs and business. Most of the populations live 
below the poverty line and due to less education there is a lack of awareness of T2D as a 
chronic disorder. T2D patients facing a poor health care system which is unable to 
accommodate the more newly diagnosed T2D cases which ultimately increasing the 
economic burden on the society. Rate of diabetes increase was recorded in Asia rapidly 
over short periods (Chan et al., 2009) and in south Indians its prevalence is expected to 
increase up to 150% (Hossain et al., 2007). 
According to the current study, diabetes prevalence was most common among 
middle aged (41-60 years) population. International Diabetes Federation (IDF, 2003) also 
reported the most affected age group with diabetes was between 45 and 64 years which is 
the most productive and active period of life. Urban population of Pakistan was at higher 
risk of diabetes development as well as most of the women in urban areas was 
overweight (BMI > 25) and diagnosed with diabetes at early age (≤ 35) in comparison to 
rural population. The onset of diabetes in Asian population was reported at relatively 
young age which varied according to culture, ethnicity and urbanization (Chan et al., 
2009). There was a higher prevalence of diabetes in Indian population because lifestyle or 
environmental factors play an important role in the onset of diabetes and urban 
population was identified at more risk (Ramchandran et al., 1992; Ramchandran et al., 
2002). Physical inactivity and sedentary life style (watching TV and office jobs) in urban 
residents can be the reason of early diagnosis of T2D. Most of the women in Pakistan are 
housewives and have a sedentary life style so this can be a basic reason for obesity. Due 
to decrease in physical activity the higher BMI and central obesity was reported as the 
cause of increase in T2D patients in India (Ramachandran et al., 2010). The distribution 
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of BMI showed that patients with positive family history of diabetes were diagnosed with 
the disease at BMI lower than normal < 25. Positive family history of diabetes in rural 
population can be due to first cousin marriages which are very common in rural areas of 
Punjab appeared as the reason of early onset of T2D with BMI < 25. The positive family 
history of diabetes reported as a strong predictor for the onset of diabetes and an indicator 
for the screening of individuals at the risk of developing T2D (Hu et al., 2009). A study 
in Indians diabetes patients revealed a very lower value of BMI than obesity can cause 
the insulin resistance (Ramchandran et al., 2002). However the data from USA provided 
evidence that rate of diabetes increasing in adults was attributed to the obesity (Mokdad 
et al., 2000). It was concluded that Asian population with BMI lower than normal 25 
kg/m² (which is not considered as overweight according to WHO) were found at risk of 
developing diabetes and cardiovascular complications. A number of health surveys in 
Asian countries suggested that overweight and obesity is going to increase (Yoon et al., 
2006). It was reported in a study that Metabolic Syndrome going to increase 
proportionally with obesity in developing countries (Misra et al., 2008). It was interesting 
that prevalence of Metabolic Syndrome in males of urban areas was reported as 
significantly higher in comparison to rural areas which may be due to change in lifestyle 
and nutrient rich diet (Ramírez-Vargas et al., 2007). Contrary to our observation, the 
body fat content was found to be higher in Asian Indian in comparison with western 
populations (Shafi et al., 2004). 
Awareness about disease care and treatment was negligible where 42.81% of 
patients which did not go for regular medical examination (not even once a year). This 
poor management can be the major reason for diagnostic complications at late or end 
stages usually leads to cause mortality. Distribution of Cardio-Vascular diseases was 
11.6% among diabetic patients. West Indies is a third world country with increasing 
number of diabetics and 35% of diabetic patients were with at least one of CVD 
(Ferguson et al., 2011). Khuwaja et al. (2004), also predicted a higher trend in increase of 
subjects with diabetes which were suffering from macro-vascular complications. Present 
study indicated that the distribution of retinopathy and nephropathy were higher in rural 
population (37.65%) than the urban population (11.8%) indicated carelessness of diabetes 
management, illiteracy and unawareness were the reasons of these complications. Long 
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duration of the diabetes also appeared as the cause of cardiovascular diseases, kidney 
failure and retinopathy. The renal diseases in diabetes patients are going to increase in 
south Asians (Fischbacher et al., 2003). Onset of diabetes at young age and long duration 
of disease placed Asian patients at high risk for CVD and nephropathy. 
Mean estimated annual cost per patient was 19157.51 PKRs (210.92 US$) in 
Pakistan. Patients with the income 10,000-20,000 PKRs were bearing significantly higher 
disease cost in comparison to other lower and higher income group. However the cost of 
treatment and management varies from population to population due to variation in 
disease management, awareness, treatment with insulin or oral medication, complications 
and health care system. The calculated cost of diabetes management varies from country 
to country e.g. 13 US$ to 11,157 US$ in Bangladesh and USA annually (Brandle et al., 
2003). The median annual direct medical cost for an African-American man with T2D 
was 82% compared with the cost of a white population in USA (1,380 US$) (Brandle et 
al., 2003). Cost of disease care and management varied among the patients due to change 
of their life style, diabetes duration and complications. Patients with the more income 
along higher education were spending significantly higher cost to manage the disease as 
compare to groups with low income and less education. Overall the management of T2D 
in the population aged over 45 years and early screening in younger ages has shown to be 
cost effective in US population (Kahn et al., 2010).  
Patients with long duration of diabetes, complications and insulin treatment were 
spending significantly higher amount on disease management. Treatment with insulin had 
significantly more management cost in comparison to oral medication in Pakistan where 
25.95% of patients were found using insulin in diabetes treatment. In Switzerland, 19% 
of T2D patients were receiving insulin treatment comparatively which is less then 
Punjabi population of Pakistan (Kaisar et al., 2012). Subjects with insulin treatment have 
1.59 –1.9 folds higher the cost for each treatment than those who used oral medication for 
treatment in USA (Kahn et al., 2010). In line to the current study treatment cost escalated 
with increased diabetes duration and complications in UK, Canada and Brazil (Caro et 
al., 2002; O'Brien et al., 2003; Bahia et al., 2011). Diabetes complications in Indians 
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were nephropathy; retinopathy and cardiovascular diseases identified as the basic reason 
of economic burden on diabetic population (Chaturvadi et al., 2007). 
Even 42.3% of the diabetes patients were found illiterate in Pakistan and a 
number of people lives below poverty line. In relevance to our study Gnavi et al., (2008) 
reported that diabetes was more frequent among low educated and low income population 
of Italy. WHO reported about 70% of mortalities in lower to lower middle income 
population of Pakistan, India, Vietnam, and Cambodia due to diabetes (WHO, 2005; 
Gnavi et al, 2008).  
Diabetes is a polygenic disorder and a number of genetic variants combine with 
the environmental factors for the disease onset. On the basis of genetic mutations as the 
reason for onset of metabolic syndrome current study identified twenty nine SNPs in 
Punjabi population of Pakistan. Rees et al. (2013), studied a very few number of diabetes 
related SNPs in immigrants and Azad Jammu Kashmir subjects of Pakistan. This data is 
not quite enough to represent the scenario of diabetes associated genes in diverse and 
large population of Pakistan. Up to our knowledge it’s the first study from Punjab 
reporting the genetic association of diabetes.  
Province Punjab of Pakistan is a multicultural and multiethnic region with 
specific traditions from generation to generation. Caste system is strong with caste to 
caste or cousin marriages among Punjabis and this tradition narrows down the gene pool 
with few genetic recombinations. Even this mechanism sometimes disturbed the allele 
and genotype frequency in the population that ultimately leads to the violation of Hardy-
Wien berg Equilibrium. Deviation of few genetic markers (Table 4.5)  in the current 
study could not be validated for HWE in Pakistani population (HWE = P < 0.05). Salanti 
et al. (2005), primarily attributed this HWE deviation to the genotyping error. This 
possibility was ruled out for the selected samples by the confirmation of genotyping data 
by independent workers. The second possibility of deviation could be absence of random 
mating in human population and genetic drift.   
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The genome-wide associations throughout the world identified number of loci 
associated with T2D. The gene KCNQ1 with 3 SNPs was genotyped and rs234864 was 
associated with diabetes. Current study is the 1st to report the association of rs234864 
while rs2237892 and rs2237895 were not associated with diabetes. The KCNQ1 is a most 
replicated gene found to be associated with 20–30% increased risk of diabetes in several 
Asian populations but association was rare in Caucasians (Unoki et al., 2008; Yasuda et 
al., 2008). In a meta-analysis of Asian population rs2237892-KCNQ1 was significantly 
increasing the risk of T2D in Koreans, Japanese, Chinese and Malaysian population but 
no association was detected in Indian population (Takeuchi et al., 2009; Li et al., 2014). 
Replication of rs2237895 in Punjabi population lack an association with T2D while 
Jonsson et al. (2009), reported the association of rs2237895 with diabetes in Swedish 
individuals. Contrary to the present study the rs2237895-KCNQ1was associated with the 
risk of diabetes development (P <0.05) in Punjabi population of India (Been et al., 2011). 
Four haplotypes were associated with diabetes onset in Pakistanis on chromosome 11 
containing KCNQ1 and NELL1genes. In Indians the haplotype analysis suggested that 
association of diabetes risk with three above memtioned SNPs in KCNQ1 gene and it 
appeared to be mediated by beta-cell function (Been et al., 2011).  
The rs1801282 was associated with risk of diabetes at single site and genotype 
level (P < 0.05) in Punjabis. The association between the rs1801282 and T2D has been 
the focus of several meta-analyses and this genetic variant was associated in some studies 
with diabetes whereas reported protection against diabetes in few races (Douglas et al., 
2001; Altshuler et al., 2000; Memisoglu et al., 2003; Radha et al., 2006; Gouda et al., 
2010). In line to our study Radha et al. (2009), reported that Pro 12Ala did not reduce the 
risk of diabetes in Indians (South Asians). Similar findings were observed in Malaysians 
and Chinese who were residing in Singapore. Even the Pro12Ala (rs1801282) was 
associated with the risk of onset of diabetes in Europeans and Chinese population of 
Hong Kong (Kilpeläinen et al., 2008; Ho et al., 2012). A contrary study from France and 
Switzerland suggested that there was a positive association of Pro12Ala with T2D in 
individuals with obesity (BMI ≥ 30 kg/m2) (Liu et al., 2008).  
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No association was detected between rs734312 (WFS1) and T2D in south Asian 
(Pakistani) population (P - 0.1337) in a single site analysis but was associated at 
genotype level (P < 0.05). In general SNPs in WFS1 gene play a role in the pathogenesis 
of T2D and altered β-cell function such as cause impaired response of insulin to the 
glucose stimulation (Chistiakov et al., 2010). Minton et al (2002) provide the evidence 
that variants in WFS1 gene associated with the susceptibility of T2D. The rs734312 was 
identified as associated with diabetes risk (P < 0.05) in UK, French and Ashkenazi 
populations (Sandhu et al., 2007; Cheurfa et al., 2011). The lack of association at single 
site between rs734312 and T2D might be due to difference in ethnicity and distribution of 
allele frequencies.  
The HHEX/IDE (rs7923837/rs7910977) locus was involved in pathogenesis of 
diabetes (P = 0.006/P = 0.0163) in central Punjab of Pakistan. It was concluded that 
genetic variations at IDE confer clinically significant risk of diabetes in Caucasians 
(Florez et al., 2006; Pascoe et al., 2007). Two studies in China reported the rs7923837 as 
a risk for diabetes in Han Chinese (Han et al., 2010) and population of Shangai (P – 
0.008) where as it was not a susceptible genetic variant for individuals in closely relatd 
population of Beijing (Wu et al., 2008). Differences in the distribution of risk allele 
frequencies in HHEX was attributed to differences in risk of diabetes development in 
closely related casts and various ethnic groups throughout the world (Maggie et al., 
2008).  
Chromosome 1 was previously reported as a susceptible loci linked with T2D in 
different populations. Current study is the first to report the association of POU2F1 and 
NPPA in south Asian population. Three SNPs from POU2F1 gene (rs10918682, 
rs2146727 and rs3767434) were selected and out of these three rs10918682 (P - 0.04) 
and rs3767434 (P - 0.02) were associated with the risk of T2D in Pakistani population. 
This gene was studied only in East Asians (Chinese) and known to act as a transcription 
factor which plays a role in the genes regulation and cell cycle. It is located on 
chromosome 1q24 and this gene depicted a linkage of T2D in Chinese population of 
Hong Kong (Ng et al., 2008; Ng et al., 2010). Fine-mapping study of 1q chromosome 
identified the two loci associated with diabetes (NOS1AP and ASH1L/PKLR) in 
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Europeans but not in other races (Voight et al., 2010). The data of international 1q 
consortium demonstrated the association or linkage of this region (1q21-25) with T2D 
from eight European and East Asian populations (Prokopenko et al., 2009). The rs5063 
appared as a novel SNP from NPPA gene and found to be associated with diabetes (P < 
0.05) in Pakistanis. Moreover, rs5063 is not replicated in reference to association with 
diabetes in any ethnicity throughout the world. There was a lack of association between 
rs5064 from NPPA with onset of diabetes [(P = 0.339, OR = 1.345 (0.767, 2.357)]. Even 
it did not depicted association with hypertension. The rs5064 form NPPA was reported to 
be associated with hypertension in a follow up study of Americans (Conen et al., 2007). 
The rs7756992 from CDKAL1 was not associated with the diabetes risk [(P = 
0.557, OR = 0.897 (0.647, 1.244)] in Pakistani population. Few studies inline to our 
results did not find any relationship between CDKAL1 variants and type 2 diabetes in the 
Austrian, Norwegian and Pima Indian populations (Cauchi et al., 2008; Hertel et al., 
2008; Rong et al., 2009). The CDKAL1 with rs7756992 was identified as a susceptible 
gene for T2D in some Asians and Europeans (Dehwah et al., 2010). Moreover, a number 
of studies reported significant association between T2D and rs7756992 in the Han 
Chinese, Hong Kong, Israeli Ashkenazi and Japanese populations (Liu et al., 2008; 
Steinthorsdottir et al., 2007; Horikawa et al., 2008; Tabara et al., 2009). The association 
between the rs7756992 and T2D risk remained controversial in different populations due 
to difference in distribution of allele and genotype frequency among different races. 
The genetic variant rs1800796 from IL6 was significantly associated with the 
development of T2D [(P = 0.001, OR = 0.394 (0.265, 0.584)] in Pakistanis. It was also 
significantly associated with diabetes at genotype level (P = 0.001). It was reported that 
elevated IL6 levels in plasma were associated with hypertension in females of Hong 
Kong (Cheung et al., 2011). Interleukin 6 was found to be involved in the increase of 
diabetes risk in Europeans and Americans (Pradhan et al., 2001; Spranger et al., 2003). 
The genetic variants in IL6 were also reported to be associated with risk of cardiac 
diseases in US and Indian population (Maitra et al, 2008; Fragoso et al., 2010). 
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In current study the rs5443 from gene GNB3 associated with diabetes at genotype 
level (P = 0.016) but was not associated at single site analysis (allele). No statistically 
significant association was observed between the rs5443 and the susceptibility of diabetes 
in the South Indian population (Chandrasekaran et al., 2012). Hsiao et al. (2013), 
described that rs5443 in GNB3; analysis of single locus did not show any significant 
association on the risk of obesity in Taiwanese population. Moreover, Suwazono et al. 
(2004), reported the lack of rs5443 association with overweight in Japanese population. 
Although Brand et al. (2001), reported that in men but not in women, the T allele and TT 
genotype were more prevalent in obese subjects in a German population. Kiani et al. 
(2005), revealed the positive association of rs5443 polymorphism with type 2 diabetes in 
the Emirati population. In Asian Indian (US residing) populations, minor associations 
between C825T and T2D were shown by Pemberton et al, (2008). Parra et al. (2004), 
reported the lack of association of GNB3 with diabetes in the Hispanic American 
population. Moreover Andersen et al. (2006), showed only minor associations which 
were not statistically significant in the Danish population. 
Cholesteryl Ester Transfer Protein (CETP) mediates the transfer of cholesteryl 
esters and triglycerides between lipoprotein particles and plays a crucial role in reverse 
cholesterol transport. The association of variations in the CETP gene with acute 
myocardial infarction remains unclear (Meiner et al., 2008). The rs1800775 from CETP 
did not show any relationship with the myocardial infarction in diabetes patients (P - 
0.696). The same SNP was increasing the risk of coronary heart diseases in Chinese 
population (Wang et al., 2013). 
Inter Lukin1-α (IL1- α) with rs1800587 and Inter Lukin1- β (IL1-β) with 
rs1143634 did not show any relationship with the development of T2D at allele and 
genotype levels (P > 0.05). However rs1143634 in IL1-β was with only two genotypes 
(CC, CT). In present study the rs1800587 and rs1143634 showed association with T2D at 
haplotype level. It was reported that insulin producing beta – cells within pancreatic islets 
specifically prone to IL1-β  by inducing destruction and loss of function as well as insulin 
resistance in obesity (Maedler et al., 2009). Luotola et al. (2011), reported in genetic 
analysis that rs1800587 (IL1-alpha) and rs1143634 (IL1-beta) were significantly 
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associated with diabetes (P values 0.002 and 0.023 respectively). IL1-alpha and IL1-beta 
were associated with central obesity (P < 0.05) in western Australian population (Luotola 
et al., 2009). In a European study it was reported that IL1-beta was associated with 
diabetes and its minor allele was found to be associated with higher level of blood 
glucose in comparison to major allele (Syed et al., 2004). In general the polymorphism in 
IL1A (rs1800587) was associated with the obesity and it has a critical role in the obesity 
development which ultimately leads to diabetes (Um et al., 2011). 
A significant association was seen between PON1 gene (rs854560) with diabetes 
[P < 0.05, OR = 0.663 (0.455, 0.965)] and TT homozygous was associated with 0.690 
frequency in cases that is higher in comparison to control (0.571). In contrast to current 
study results there was no evidence of association of rs854560 polymorphism with 
diabetes in Han Chinese (P = 0.370) (Zhang et al., 2013). The L55M (rs854560) 
influence activity of PON1 gene, antioxidant activity of this gene play a role in 
prevention of oxidative stress, its role in pathophysiological process associated with 
atherosclerosis and diabetes mellitus. This SNP associated with changes in concentration 
of the enzyme (Veiga et al., 2011). Polymorphism in PON1 gene was also reported to be 
associated with diabetic retinopathy (Kao et al., 1998).  
An association of rs1062535 (ITGA2) was observed with cardiac complications in 
Pakistani diabetics. A study in china also reported the association of genetic 
polymorphisms in ITGA2 with ischemic strokes in T2D subjects (Andrea et al., 2011). 
Whereas Li et a.l. (2008), reported a lack of ITGA2 gene association with complications 
of diabetes. 
In conclusionT2D is increasing at alarming level due to urbanization and onset of 
diabetes in younger ages of both genders with higher risk of complications such as 
retinopathy, nephropathy and cardiovascular diseases. South Asians are at high risk of 
developing diabetes at BMI less than normal (BMI < 25). There is a lack of diabetes care, 
awareness and disease management in Pakistani Population which resulted in increase of 
poor health conditions and economic burden on society. Twnty two candidate genes 
along twenty nine SNPs for diabetes were studied in Pakistani population by performing 
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a case control analysis. The POU2F1 (rs10918682, rs2146727 and rs3767434), ITGA2 
(rs1062535) and NPPA (rs5064, rs5063) are novel in Pakistanis. The study demonstrated 
that the genetic variants in IDE, HHEX, KCNQ1, ITGA2, PON1, WFS1, IL1a, IL1b, 
CDKAL1, GNB3, PPARG, NPPA, IL6 and POU2F1 play a role in the development of 
T2D in Pakistani population. We confirmed that the SNPs in KCNQ1, IDE, PON1, 
CDKAL1 and IL6 were associated with the risk of T2D. The genes NPPA and ITGA2 
were associated with the hypertension and cardiac diseases in diabetics. As PPARG 
studied in different ethnicity groups, it’s found to be protective against diabetes in 
Europeans while it was making the south Asians at risk of diabetes. A few genes which 
have been studied throughout the world such as LPL, CETP, ADRB3 and TCF7L2 did not 
showed any association with the onset of diabetes in Pakistani population. Further studies 
in this population with prospective genetic data and also information on environmental 
factors are required to expose superiorly the effects of these genetic variants on disease 
risk and their interaction with environment. Survey studies on diabetes can greatly 
contribute to target the communities with high risk of developing diabetes which in turn 
will be useful in the prevention of disease. There is a need for replicative studies at large 
scale to determine the role of genetic variants in pathology of diabetes which can be 
helpful in early prediction as well as control and prevention of this disease. 
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Annexure I 
 
 
Patient No._____________________ Date: _________________________ 
 
Information Performa for Diabetes Patients 
Personal Information: 
Patient’s Name:  
 
____________________________________________________ 
Age: 
 
______________________________________________________________ 
Mobile Phone Number: 
 
_____________________________________________ 
Residence Phone Number: 
 
____________________________________________ 
Official Phone Number:  
 
_____________________________________________ 
Postal Address: 
 
_____________________________________________________ 
_____________________________________________________________________ 
 
_____________________________________________________________________ 
 
Residential Address: 
 
________________________________________________ 
_____________________________________________________________________ 
 
_____________________________________________________________________ 
 
Official Address: 
 
___________________________________________________ 
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_____________________________________________________________________ 
 
_____________________________________________________________________ 
 
Age at the Time of Diagnosis of Diabetes:  _________________________________ 
 
 
 
 
Education:  
□ Illiterate 
□ Up to Primary 
□ Secondary to Intermediate 
□ Graduate and Above 
 
Employment Status:  
□ Jobless 
□ Laborer 
□ Housewife 
□ Office Job/Businessman 
 
Monthly Household Income: 
 
□ Up to 5000  □ 5001 – 20000  □ > 20000 
Socioeconomic Status (SES):  
□ Low SES 
□ Middle SES 
□ High SES 
 
Duration of Diabetes:  
□ 1–5 Years 
□ 6–10 Years 
Age of Patient: 
25-40 □ ___________ 
41-60 □ ___________ 
 
Sex: 
♀ □  
♂ □  
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□ >10 Years 
 
Mode of Treatment:  
 
 
 
Weight: -
_____________________________________________________________ 
 
Height: ______________________________________________________________ 
 
Blood Pressure: _______________________________________________________ 
 
Body Mass Index (BMI):    
□ Under Weight     
□ Normal   
□ Over Weight     
□ Obese 
□ Severely Obese 
 
Diet Plan: 
Meals per Day: 
□ Once     
□ Twice  
□ Thrice     
□ Four Times 
□ Five Times 
 
 
Diet Management According to Plan 
□ Fruits/Salads 
□ Through Diet and Exercise 
□ Oral Medication 
□ Insulin 
Co-morbidities: 
□ No co-morbidity 
□ 1 co-morbidity  
□ >1 co-morbidity 
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□ Carbohydrates  
□ Proteins 
□ Saturated/Unsaturated Fats 
 
Life Style: 
□ Stress 
□ Smoking Active/Passive 
□ Exercise 
□ Hypertension 
 
  
Family History:  
 
 
 
 
HbAIC 
             
____________________________ 
Blood Glucose Level Check Frequency:   
                            
____________________________ 
Complete Medical Checkup Frequency/Year: 
                                  
____________________________ 
Treatment Regularity: 
 
____________________________ 
Regular Advice from Physician: 
 
____________________________ 
Eating Behaviors (Overdose of High Glycemic Index Foods):  
 
 
 
Other Complications with Diabetes: 
□ Parents 
□ Sister 
□ Brother 
□ Day  
□ Week 
□ Month  
□ Occasionally 
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□ Nephropathy 
□ Retinopathy 
□ Cancer   
□ Cardiovascular Disease 
□ Other 
 
In case of other, Specify: _____________________________________________ 
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Consent Form: 
 
NOTE: All the data presented in the following performa by the patient is confidential and 
can only be used for the purpose of scientific study and research.  
 
 
I _________________________________________ am aware that I have signed a letter 
of consent concerning the information presented in this performa by me and hereby 
declare that I have no objection against the use of information in this data for scientific 
study and research purposes (only). 
 
 
 
Signatures of the Patient 
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Annexure II 
3.6.3 Agarose Gel Electrophoresis 
It was used to determined the of PCR products (presence or absence) and quantify the 
size (length of the DNA molecule) of the product. 
Materials needed: 
Agarose 
TAE Buffer 
6X Sample Loading Buffer 
DNA ladder standard 
Electrophoresis chamber 
Power supply 
Gel casting tray and combs 
Recipes: TAE Buffer 
4.84 g Tris Base 
1.14 ml Glacial Acetic Acid 
2 ml 0.5M EDTA (pH 8.0) 
maked the total volume up to 1L with water 
Added Tris base to ~900 ml H2O. Added acetic acid and EDTA to solution and mixed. 
Poured mixture into 1 L graduated cylinder and added H2O to a total volume of 1 L. 
For convenience a concentrated stock of TAE buffer of 10X was made and was diluted 
with water to 1X concentration before use. 
6X Sample Loading Buffer 
1 ml sterile H2O 
1 ml Glycerol 
Enough bromophenol blue to make the buffer deep blue (~ 0.05mg) 
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Preparing the Agarose gel 
Measure 1 g of Agarose powder and add it to a 500 ml flask. Add 100 ml TAE 
Buffer to the flask. Heated the agarose in a microwave until the solution became clear. 
The solution was cooled to about 50-55°C and added 5 l of Ethidium Bromide (Sigma 
E7637) in 100 ml solution, swirling the flask occasionally to cool evenly. Place the 
combs in the gel casting tray. Poured the melted agarose solution into the casting tray and 
cooled it until it is solid (it should appear milky white). Carefully pull out the combs. 
Placed the gel in the electrophoresis chamber. Added enough TAE Buffer so that it’s 
about 2-3 mm of buffer over the gel. 
Loading the gel 
Added 3 l of Sample Loading Buffer to 2l of PCR product on a thin film and 
mix it. The order of the samples loading was recorded. Carefully pipette 5 l of each 
sample Loading Buffer mixture into separate wells in the gel. Pipette 2 l of the DNA 
ladder (1kb, Fermentas) into at least one well of on the gel. 
Running the gel 
Placed the lid on the gel box, connecting the electrodes. Connected the electrode 
wires to the power supply, making sure the positive (red) and negative (black) were 
correctly connected. Turned on the power supply, about 100 volts. Checked to make sure 
the current is running through the buffer by looking for bubbles forming on each 
electrode. Checked that the current running in the correct direction by observing the 
movement ofthe blue loading dye. The power run until the blue dye approaches the end 
of the gel. Turn off the power. Disconnected the wires from the power supply. Remove 
the lid of the electrophoresis chamber. Carefully removed the tray and gel and DNA 
bands were observed (BioRad, Gel doc system) 
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Master Mix (5x) Composition for PCR 
MilliQ water 360 µl 
dNTPs  (10 µl)100 µl 
MgCl2    (.5M) 40 µl 
      10x long buffer 500 µl 
